 Patent Application Title |
Patent App Num. |
Date |
| Method and device for identification of nucleated red blood cells from a maternal blood sample | 20120021508 | 20120126 |
| A method for concentrating and isolating nucleated cells, such as a maternal and fetal nucleated red blood cells (NRBC's), in a maternal whole blood sample. The invention also provides methods and apparatus for preparing to analyze and analyzing the sample for identification of fetal genetic material as part of prenatal genetic testing. The invention also pertains to methods and apparatus for discriminating fetal nucleated red blood cells from maternal nucleated red blood cells obtained from a blood sample taken from a pregnant woman.
... |
| Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing | 20120003635 | 20120105 |
| Embodiments of this invention provide methods, systems, and apparatus for determining whether a fetal chromosomal aneuploidy exists from a biological sample obtained from a pregnant female. Nucleic acid molecules of the biological sample are sequenced, such that a fraction of the genome is sequenced. Respective amounts of a clinically-relevant chromosome and of background chromosomes are determined from results of the sequencing. The determination of the relative amounts may count sequences of only certain length. A parameter derived from these amounts (e.g. a ratio) is compared to one or more cutoff values, thereby determining a classification of whether a fetal chromosomal aneuploidy exists. Prior to sequencing, the biological sample may be enriched for DNA fragments of a particular sizes.
... |
| Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing | 20120003636 | 20120105 |
| Embodiments of this invention provide methods, systems, and apparatus for determining whether a fetal chromosomal aneuploidy exists from a biological sample obtained from a pregnant female. Nucleic acid molecules of the biological sample are sequenced, such that a fraction of the genome is sequenced. Respective amounts of a clinically-relevant chromosome and of background chromosomes are determined from results of the sequencing. The determination of the relative amounts may count sequences of only certain length. A parameter derived from these amounts (e.g. a ratio) is compared to one or more cutoff values, thereby determining a classification of whether a fetal chromosomal aneuploidy exists. Prior to sequencing, the biological sample may be enriched for DNA fragments of a particular sizes.
... |
| Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing | 20120003637 | 20120105 |
| Embodiments of this invention provide methods, systems, and apparatus for determining whether a fetal chromosomal aneuploidy exists from a biological sample obtained from a pregnant female. Nucleic acid molecules of the biological sample are sequenced, such that a fraction of the genome is sequenced. Respective amounts of a clinically-relevant chromosome and of background chromosomes are determined from results of the sequencing. The determination of the relative amounts may count sequences of only certain length. A parameter derived from these amounts (e.g. a ratio) is compared to one or more cutoff values, thereby determining a classification of whether a fetal chromosomal aneuploidy exists. Prior to sequencing, the biological sample may be enriched for DNA fragments of a particular sizes.
... |
| Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women | 20110318320 | 20111229 |
| The present invention relates to nutritional supplements to be administered to, or to be taken by, women desiring to become pregnant, and pregnant and nursing women. The nutritional supplements of this invention have a unique blend of vitamins, minerals, lycopene, co-enzyme Q10, DHA, docusate (such as docusate sodium), folic acid, and a nutritionally acceptable carrier therefor. The invention includes specific nutritional supplements for the uses set forth above.
... |
Subscribe to updates on this page: Pregnant RSS  |
| Diagnosing fetal chromosomal aneuploidy using massively parallel genomic sequencing | 20110318734 | 20111229 |
| Embodiments of this invention provide methods, systems, and apparatus for determining whether a fetal chromosomal aneuploidy exists from a biological sample obtained from a pregnant female. Nucleic acid molecules of the biological sample are sequenced, such that a fraction of the genome is sequenced. Respective amounts of a clinically-relevant chromosome and of background chromosomes are determined from results of the sequencing. The determination of the relative amounts may count sequences of only certain length. A parameter derived from these amounts (e.g. a ratio) is compared to one or more cutoff values, thereby determining a classification of whether a fetal chromosomal aneuploidy exists. Prior to sequencing, the biological sample may be enriched for DNA fragments of a particular sizes.
... |
| Foods and beverages for pregnancy and lactation | 20110311684 | 20111222 |
| The invention generally relates to nutrient enhanced foods and beverages which include certain levels of the most current Daily Recommended Intakes of macronutrients and Micronutrients, and the rationale for increased allowances during pregnancy. The foods and beverages of the invention generally comprise one or more macronutrients, vitamins and minerals recommended for consumption by pregnant or lactating women in an amount that is effective for enhancing the nutrition of pregnant and lactating women, and that is not harmful to developing fetuses or breast-feeding babies. In particular, the invention provides high doses of more easily absorbable iron to increase bioavailability of both iron and calcium which normally are not ingested in the needed doses, or are usually ingested via hard to swallow and digest prenatal, iron and calcium... |
| Method and device for identification of nucleated red blood cells from a maternal blood sample | 20110311960 | 20111222 |
| A method for concentrating and isolating nucleated cells, such as a maternal and fetal nucleated red blood cells (NRBC's), in a maternal whole blood sample. The invention also provides methods and apparatus for preparing to analyze and analyzing the sample for identification of fetal genetic material as part of prenatal genetic testing. The invention also pertains to methods and apparatus for discriminating fetal nucleated red blood cells from maternal nucleated red blood cells obtained from a blood sample taken from a pregnant woman.
... |
| Electrode and electrode positioning arrangement for abdominal fetal electrocardiogram detection | 20110306862 | 20111215 |
| The invention relates to large area electrodes suitable for use in a fetal heart rate monitoring systems. The electrode comprises: a cutaneous gel contact (10) for sensing fetal electrocardiogram signals from a human pregnant subject; an electrical conductor (12) electrically connected to the gel contact (10) so as to define a first electrical contact region; a connector (14) in electrical contact with the electrical conductor (12) for connection to a lead wire; and a substructure (16) for attachment to a human pregnant subject. The gel contact (10) and the electrical conductor (12) are arranged on the substructure (16) to allow a contact surface (11) of the gel contact (10) to be in electrical communication with the skin of a human pregnant subject to define a second... |
| Prenatal enzyme replacement therapy | 20110300143 | 20111208 |
| The invention also contemplates a method for treating a metabolic disorder, such as HPP, in a fetus or embryo were a protein is administered to a pregnant mother. The fusion protein comprises a Fc fragment of an IgG1 antibody peptide-bonded to TNSALP. The protein crosses the placenta of the mother and enters the fetal blood stream. The protein is taken up into fetal tissue such that the TNSALP restores normal metabolic activity in the fetus.
... |
| Elastic reinforced inframammary curve bra | 20110300774 | 20111208 |
| A contouring support bra made from soft stretchable cotton knit and light, and power-net support fabrics particularly suited for pregnant and nursing women for comfortably providing an alluring, lifted tear drop breast shape analogous to that provided by properly-fitted traditional underwire bra structures.
... |
| Method for determining the risk of preeclampsia using pigf-2 and pigf-3 markers | 20110294227 | 20111201 |
| The present invention relates to a method for determining the risk of a pregnant woman developing pre-eclampsia. The method comprises i) determining the level of one or more biochemical markers in a sample obtained from a pregnant woman, and ii) comparing the level of the at least one biochemical marker in the sample with the level of the same biochemical marker in a control sample. A difference in the level of the biochemical marker in the sample relative to the control sample is indicative of an increased risk of developing pre-eclampsia. The isoform biochemical markers are preferably P1GF-2 and P1GF-3. The present invention relates also to a method for determining whether a pregnant woman has pre-eclampsia and as well as a kit for assessing the risk... |
| Adhesive strap for foetal monitoring transducers and the like | 20110282178 | 20111117 |
| The invention relates to a system (10) for attaching to the stomach (24) of a pregnant woman, said system comprising a bracket (11) and strapping means; wherein said bracket comprising strapping engaging means (16) for releasable engaging said strapping means with said bracket (11) and/or for adjusting the effective length of said strapping means; wherein said bracket (11) either comprising a monitoring device (12); or comprising means for accommodating a separate monitoring device (12); wherein said strapping means comprise two separate straps (18) each having two ends; wherein one end of each of said separate straps (18) being an adhesive end (20) for adhering onto the skin of said woman's stomach (24).
... |
Subscribe to updates on this page: Pregnant RSS |
| Prediction and prevention of preeclampsia | 20110281801 | 20111117 |
| The present disclosure relates to methods for detecting an increased risk of preeclampsia, determining the presence of preeclampsia, reducing the likelihood that preeclampsia will develop and treating preeclampsia. It also provides methods of measuring relaxin levels in a biological sample of a pregnant woman.
... |
| Controlled copper leach recovery circuit | 20110277593 | 20111117 |
| The present invention relates generally to a process for controlled leaching and sequential recovery of two or more metals from metal-bearing materials. In one exemplary embodiment, recovery of metals from a leached metal-bearing material is controlled and improved by providing a high grade pregnant leach solution (“HGPLS”) and a low grade pregnant leach solution (“LGPLS”) to a single solution extraction plant comprising at least two solution extractor units, at least two stripping units, and, optionally, at least one wash stage.
... |
| Measuring and displaying the propagation velocity of uterine action potentials to determine the onset of labor | 20110270118 | 20111103 |
| A method and system to examine and measure the propagation velocity of electrical activity in pregnant patients, labor and non-labor patients at term and preterm, and non-pregnant patients, thereby providing valuable information regarding the state of a patient's uterus. The method can include obtaining uterine EMG signals from a series electrodes, processing the raw uterine EMG signal in a signal processing module and assessing the temporal interval between adjacent electrodes. The propagation velocity can then be estimated by averaging the time required for the uterine EMG signal to traverse a distance between adjacent electrodes.
... |
| Ultrasonic apparatus for measuring a labor progress parameter | 20110257529 | 20111020 |
| An apparatus (10) for measuring one or more labor progress parameters (25) as the dilation of the endocervical canal (8), the rotation and the position of the head (4) of the foetus (3) during the descent, the duration and the intensity of the uterine contractions, other morphological and physiological parameters, without introducing foreign objects into the body of a pregnant woman (2) and independently from the sensitivity of the operator. The apparatus (10) comprises automatic means for tracking, in a sequence of ultrasound images (11,12) that are obtained by an ultrasound probe (1), one or more regions of interest (ROI, 21), that may be both two-dimensional or three-dimensional and are centred about anatomic reference points (28) that define said parameters selected in a reference image by... |
| Non-invasive detection of fetal genetic traits | 20110251076 | 20111013 |
| Blood plasma of pregnant women contains fetal and (generally >90%) maternal circulatory extracellular DNA. Most of said fetal DNA contains ≦500 base pairs, said maternal DNA having a greater size. Separation of circulatory extracellular DNA of <500 base pairs results in separation of fetal from maternal DNA. A fraction of a blood plasma or serum sample of a pregnant woman containing, due to size separation (e.g. by chromatography, density gradient centrifugation or nanotechnological methods), extracellular DNA substantially comprising ≦500 base pairs is useful for non-invasive detection of fetal genetic traits (including the fetal RhD gene in pregnancies at risk for HDN; fetal Y chromosome-specific sequences in pregnancies at risk for X chromosome-linked disorders; chromosomal aberrations; hereditary Mendelian genetic disorders and corresponding genetic markers; and traits decisive... |
| Prenatal sound delivery system | 20110249833 | 20111013 |
| A flexible band may be worn around the stomach of a pregnant woman. The band may have speakers safely and comfortably integrated therein to provide sound to prenatal babies. The speakers may connect to a mp3 player that may be stored in a pocket in the band.
... |
| Identifying and quantifying biomarkers associated with preeclampsia | 20110247404 | 20111013 |
| Described herein are methods for testing pregnant subjects for preeclampsia by detecting and quantifying at least one biomarker associated with preeclampsia in a biological sample from the subject.
... |
| Methods and apparatus for screening for chromosomal abnormalities | 20110246077 | 20111006 |
| This invention generally relates to methods, apparatus, and computer program code for antenatal screening for chromosomal abnormalities, in particular Down's Syndrome. A method of determining a likelihood of a fetus carried by a pregnant mother having a chromosomal abnormality, a first biological, parameter being suitable for screening said fetus for said chromosomal abnormality, the method comprising: receiving first data from a first stage of pregnancy of said mother, said first data comprising data representing a first value of said first biological parameter; receiving second data from a second, later stage of said pregnancy, said second data comprising data representing a second value of said first biological parameter; and determining likelihood data from said first and second data, said likelihood data representing the likelihood of said fetus... |
| Simple device for treating tinea unguium | 20110245785 | 20111006 |
| Provided is a device for treating tinea unguium which allows unrestricted treatment even for patients with basic diseases such as liver diseases, pregnant women and lactating patients and by which interindividual difference in the treatment can be avoided and antifungal agent for external use can be transdermally absorbed from the nail surface to the deep part of the nail economically, safely and efficiently within a short period of time without any side effects. A dome-shaped applicator, which is formed of a flexible material, which has an open part provided with a flange for adhesion and which is formed to have a larger film thickness in the periphery adjacent to the open part than the film thickness in other parts, is hermetically bonded to a surface of... |
| Fetal stimulation device | 20110245737 | 20111006 |
| A fetal stimulation device is incorporated into a garment to be worn by a pregnant woman. The garment is preferably formed of an elastic material and includes a torso portion which is arranged around the torso of the woman. An audio device and a pair of speakers are connected with the garment torso portion to deliver sound such as music or words to a fetus. The garment torso portion also includes and elongated massaging element which is arranged around the perimeter of the torso portion to deliver vibrations to the fetus. The sounds and vibrations stimulate the fetus during prenatal development. In addition, massaging and heating elements are provided in the rear of the garment to deliver vibrations and heat to the back of the woman.... |
| Non-invasive detection of fetal genetic traits | 20110245482 | 20111006 |
| Blood plasma of pregnant women contains fetal and (generally>90%) maternal circulatory extracellular DNA. Most of said fetal DNA contains ≦500 base pairs, said maternal DNA having a greater size. Separation of circulatory extracellular DNA of <500 base pairs results in separation of fetal from maternal DNA. A fraction of a blood plasma or serum sample of a pregnant woman containing, due to size separation (e.g. by chromatography, density gradient centrifugation or nanotechnological methods), extracellular DNA substantially comprising ≦500 base pairs is useful for non-invasive detection of fetal genetic traits (including the fetal RhD gene in pregnancies at risk for HDN; fetal Y chromosome-specific sequences in pregnancies at risk for X chromosome-linked disorders; chromosomal aberrations; hereditary Mendelian genetic disorders and corresponding genetic markers; and traits decisive for... |
| Kemlok adult booster seat system | 20110241388 | 20111006 |
| The KEMLOK Adult Booster Seat System is a lightweight, portable, non-mechanical, affordable system in its own carrying case, which enables people with diminished strength in the back and/or legs, such as recovering surgical patients, elderly, disabled, or obese people and/or pregnant women, to comfortably and safely attain a standing position from most seating arrangements without the assistance of another person.
... |
| Total plasma fvii/fviia levels as indicators of pre-eclampsia of pregnant females | 20110236908 | 20110929 |
| Raised total plasma FVII protein, including activated FVII (FVIIa) in pregnant females, compared with total plasma FVII protein in normal pregnancy, has been found to be an indicator of the pregnancy complication of pre-eclampsia.
... |
| Composition and method for treatment of preterm labor | 20110236392 | 20110929 |
| The invention provides a method for treating or preventing preterm labor in pregnant female subjects. The method comprises the step of administering a therapeutically effective amount of a Toll-like Receptor 9 antagonist sufficient to prevent the activation of Toll-like Receptor 9 by fetal DNA. The invention further provides compositions comprising a Toll-like Receptor 9 antagonist for use in the methods of the invention. Said compositions and methods enhance gestation and therefore improve neonatal morbidity and mortality.
... |
| Supplemental automotive restraint for pregnant women | 20110233911 | 20110929 |
| A Supplemental Automotive Restraint System for Pregnant Women has a protective shell structure with integral “Pelvic Yoke and Crotch Post”, “Breast Plate”, structural “Abdominal Bridge/Shell” over the abdomen between the “Pelvic Yoke” and the “Breast Plate”, “Shoulder Belt Retainer”, and appropriate padding and fill material, all of which work in conjunction with the standard automotive Type II lap and shoulder belt restraint system as required to be installed in all new passenger cars manufactured for sale in the United States by Federal Motor Vehicle Safety Standard No. 208 (FMVSS 208). The purpose of the “Supplemental Automotive Restraint System for Pregnant Women” is to reduce the likelihood of injury to a pregnant mother and her unborn child during maneuvering, crash, or other non-impact event of a motor... |
| Apparatus and process for monitoring a pregnant mammal | 20110224581 | 20110915 |
| Apparatus for monitoring a pregnant mammal including: a sensor (11) operatively associated with a mammal to detect a condition of delivery of said mammal; a transmission circuit (15), operatively associated with said sensor (11), to generate and transmit a notification signal (100) based on the detection of said sensor (11), and a processing unit (20) operatively associated with said sensor (11) to receive said notification signal (100) and generate a corresponding communication signal (110) for an operator. The description also covers a process for monitoring a pregnant mammal.
... |
| Simultaneous determination of aneuploidy and fetal fraction | 20110224087 | 20110915 |
| The invention provides compositions and methods for simultaneously determining the presence or absence of fetal aneuploidy and the relative amount of fetal nucleic acids in a sample obtained form a pregnant female. The method encompasses the use of sequencing technologies and exploits the occurrence of polymorphisms to provide a streamlined noninvasive process applicable to the practice of prenatal diagnostics.
... |
| Vaccine for protection against haemophilus parasuis serotype 4 in piglets | 20110014237 | 20110120 |
| The present invention pertains to the use of Haemophilus parasuis serotype 5 bacteria in the manufacture of a vaccine for administration to a pregnant sow or gilt, to protect a piglet through the intake of colostrum of the said sow or gilt after she has farrowed, against a disorder arising from Haemophilus parasuis serotype 4 bacteria. The invention also pertains to Haemophilus parasuis serotype 5 bacteria for use in the manufacture of such a vaccine.
... |
| Transformer and method of manufacturing the same | 20110001598 | 20110106 |
| There is provided a transformer and a method of manufacturing the same. The transformer includes a bobbin wound with coils; cores having center leg parts inserted from both ends of the bobbin and contacting each other; and a shielding member preventing an inflow of an impregnant into the center leg parts inside the bobbin during a varnish impregnation of the cores.
... |
| Method of supplemental automotive restraint for pregnant women | 20110001311 | 20110106 |
| The “Supplemental Automotive Restraint System for Pregnant Women” consists of a protective shell structure with integral “Pelvic Yoke and Crotch Post”, “Breast Plate”, structural “Abdominal Bridge/Shell” over the abdomen between the “Pelvic Yoke” and the “Breast Plate”, “Shoulder Belt Retainer”, and appropriate padding and fill material, all of which work in conjunction with the standard automotive Type II lap and shoulder belt restraint system as required to be installed in all new passenger cars manufactured for sale in the United States by Federal Motor Vehicle Safety Standard No. 208 (FMVSS 208). The purpose of the “Supplemental Automotive Restraint System for Pregnant Women” is to reduce the likelihood of injury to a pregnant mother and her unborn child during maneuvering, crash, or other non-impact event of a... |
| Silica removal from pregnant leach solutions | 20110000337 | 20110106 |
| The present invention relates generally to a process for removing dissolved or colloidal silica from a pregnant leach solution (“PLS”). More particularly, an exemplary embodiment of the present invention relates to a process which mixes PLS with an acid source, preferably lean electrolyte, to induce formation of colloidal silica that can then be collected and removed. Additionally, in an exemplary embodiment of the present invention, at least one silica seeding agent is added to induce formation of colloidal silica, at least one flocculant is added to induce aggregation of the colloidal silica, and a solid-liquid separation process is utilized to remove advantageous amounts or substantially all of the colloidal silica, thereby providing relief from supersaturation of dissolved silica in the metal recovery processes.
... |
| Method of automatically monitoring the movement activity of a fetus | 20100305481 | 20101202 |
| The present invention relates to a system (1) and method for automatically monitoring the movement activity of a fetus. In order to provide a simple and reliable technique for monitoring the movement activity of a fetus, a method of automatically monitoring the movement activity of a fetus is suggested, the method comprising the steps of: detecting (200) the overall movements of a pregnant female, said overall movements comprising movements of the pregnant female and movements of the fetus; detecting at least one second physiological signal (26) of the pregnant female; and—determining (300) the movement activity of the fetus by analyzing the detected overall movements of the pregnant female, analyzing the at least one second physiological signal (26) of the pregnant female, and discriminating movements of the... |
| Methods and compositions for identifying a fetal cell | 20100304978 | 20101202 |
| The present invention provides methods and compositions for specifically identifying a fetal cell. An initial screening of approximately 400 candidate genes by digital PCR in different fetal and adult tissues identified a subset of 24 gene markers specific for fetal nucleated RBC and trophoblasts. The specific expression of those genes was further evaluated and verified in more defined tissues and isolated cells through quantitative RT-PCR using custom Taqman probes specific for each gene. A subset of fetal cell specific markers (FCM) was tested and validated by RNA fluorescent in situ hybridization (FISH) in blood samples from non-pregnant women, and pre-termination and post-termination pregnant women. Applications of these gene markers include, but are not limited to, distinguishing a fetal cell from a maternal cell for fetal cell... |
| Methods for determining the risk of prenatal complications | 20100304412 | 20101202 |
| The disclosure relates to methods, medical profiles, kits and apparatus for use in determining the risk that a pregnant individual has for developing pre-eclampsia based on amounts of certain biochemical markers in a biological sample from the individual and biophysical markers. The disclosure also relates to methods, medical profiles, kits and apparatus for use in determining the risk that a pregnant individual is carrying a fetus having a chromosomal abnormality based on amounts of certain biochemical markers in a biological sample from the individual and biophysical markers.
... |
| Identification and quantification of biomarkers for evaluating the risk of preterm birth | 20100297679 | 20101125 |
| Described herein are methods for evaluating the risk of preterm birth in pregnant subjects. The methods involve detecting and quantifying one or more biomarkers associated with preterm birth in a biological sample from the subject. Also described herein are isolated biomarkers and kits useful in predicting the risk of preterm birth.
... |
| Selectively leaching cobalt from lateritic ores | 20100296988 | 20101125 |
| A heap leach process for the recovery of nickel and cobalt from a lateritic ore, said process including the steps of leaching and/or agglomerating the ore with a lixiviant that includes ferrous ions, wherein the lixiviant is able to liberate cobalt from the cobalt containing minerals within the ore in preference to nickel, to produce a cobalt rich pregnant leach solution relatively free of nickel.
... |
| Battery electrode | 20100291440 | 20101118 |
| A material suitable for use as an electrode for a battery, comprising an article which comprises carbonized fabric having an impregnant therein.
... |
| Use of neuregulin-1 in reducing brain damage | 20100286043 | 20101111 |
| Methods of reducing and/or protecting against disorders in perinatal subjects are disclosed. Such methods can be used for disorders associated with neuronal cell damage. In certain aspects, the method comprises administering a therapeutically effective amount of neuregulin or a biologically active analog with a pharmaceutical carrier to a perinatal subject. In addition, the perinatal subject can be a fetus where the neuregulin is administered to the pregnant mother. Methods for assessing whether a perinatal subject is at risk for developing a neurological disorder are also disclosed. For example, expression levels of neuregulin can be used as an indication the perinatal subject is at risk for developing a disorder associated with neuronal cell damage. Evaluating the genotype of the NRG locus in a perinatal subject can also... |
| Linoleic acid active agents for enhancing probability of becoming pregnant | 20100280116 | 20101104 |
| The present invention is directed to a methods and compositions for enhancing the probability that a subject will become pregnant. The method comprises administering to a subject a pharmaceutical composition comprising an effective amount of a linoleic acid active agent, e.g., linoleic acid, a polyunsaturated fatty acid analog thereof, etc. Also provided are kits that find use in practicing the subject methods. The subject methods and compositions find use in a variety of different applications, including but not limited to the treatment of infertility conditions.
... |
| Compositions for inducing labor and associated methods | 20100279935 | 20101104 |
| The invention discloses a pharmaceutical composition containing oxytocin and melatonin in amounts therapeutically effective for inducing labor in a pregnant human patient. Preferably, the oxytocin content is reduced to mitigate unwanted side effects and the melatonin content synergistically enhances the oxytocin's labor-inducing effectiveness. Also disclosed is a pharmaceutical composition for treatment of a pregnant human patient experiencing pre-term labor characterized by early expression of melatonin receptors in myometrial cells, the composition containing one or more agents which interfere with melatonin binding to said receptors. Additionally, the invention includes a method of treatment effective in inducing labor in a pregnant human patient, the method comprising coadministering melatonin and oxytocin to the patient and a method of treating pre-term labor in a pregnant human patient manifesting early expression... |
| Markers for prenatal diagnosis and monitoring | 20100267034 | 20101021 |
| Methods and kits are provided for diagnosing, monitoring, or predicting preeclaimpsia in a pregnant woman, trisomy 18 and trisomy 21 in a fetus, as well as for detecting pregnancy in a woman, by quantitatively measuring in the maternal blood the amount of one or more RNA species derived from a set of genetic loci and comparing the amount of the RNA species with a standard control.
... |
| Macrocyclic lactone combination compositions, vaccines and methods for producing same | 20100266628 | 20101021 |
| An injectable composition, capable of preventing or controlling parasitic, viral, or bacterial infections or diseases, for example scours, in pregnant cows and viral infections or diseases in neonatal calves by parenterally administering to each cow in a herd of pregnant cows, a dose of a combination composition comprising: (a) at least one inactivated viral component derived from rotavirus and/or coronavirus; (b) a macrocyclic lactone active compound; and (c) a pharmaceutically acceptable parenteral carrier and preservative. The injectable compositions which include eprinomectin result in extremely low milk residues.
... |
| Support pillow for pregnant woman | 20100263127 | 20101021 |
| An improved support for use by a pregnant woman to achieve greater comfort while resting or sleeping on her side. The support comprises two pillows connected together by a piece of stretchable fabric. The pillows are shaped to provide greater comfort to the woman, especially over long periods of time, compared to prior designs that employ rounded pillows. Different types of foam are used for the two pillows to tailor the degree of support for the part of the woman's body that is being supported by each pillow. The stretchable fabric enables the support to adapt to the growth of the woman during pregnancy (particularly late term pregnancy). The support may be assembled into a compact, attractive unit for storage.
... |
| Non-invasive measurement of suprasystolic signals | 20100256507 | 20101007 |
| An apparatus for assessing cardiovascular status of a mammal comprises a system for locally applying a pressure to an artery capable of restricting blood flow through said artery, a wideband external pulse transducer having an output and situated to measure suprasystolic signals proximate to said artery, and a computing device receiving said output for calculating vascular compliance values. The method described is particularly useful for determining cardiac output, assessing whether a pregnant female has preeclampsia or a patient has cardiac insufficiency, or assessing cardiac arrhythmias.
... |
| Treatment for pre-eclampsia in pregnant women using targeted apheresis | 20100247650 | 20100930 |
| This invention uses “targeted apheresis” to treat pregnant women who are at risk of developing eclampsia. “Targeted Apheresis” is a process whereby the sFlt-1 receptors responsible for causing the disease symptoms are selectively removed from the blood by passing the blood through a cartridge containing either immobilized PIGF, and/or through a cartridge containing immobilized anti-sFlt-1 antibody. The sFlt-1 receptor is bound out and the cleaned blood is returned to the patient Removal of circulating sFlt-1 receptors will diminish the risk of developing eclampsia during pregnancy.
... |
| Cholera vaccines | 20100247566 | 20100930 |
| The methods and compositions of the present invention are directed to a vaccine against Vibrio cholerae comprised of V. cholerae outer membrane vesicles (OMVs). Such vaccines are relatively stable, facilitating distribution. Inventive methods generally include administration of a vaccine against Vibrio cholerae by intranasal, intraperitoneal, oral or intragastric routes. Such vaccines confer immunity to the individual, and when administered to pregnant subjects, can be conferred to the offspring of individuals.
... |
| Method and apparatus for accommodating & covering of varying abdomen | 20100235965 | 20100923 |
| A method and apparatus for accommodating and covering a varying sized abdomen and particularly the abdomen of a pregnant woman involving leaving a zipper opening of pants not intended to cover an enlarged girth at least partially open and using a garment to cover the opening in said pants by first interconnecting a pants button on one side of the opening to a buttonhole on the other side of the opening using a buttonhole elastic having elongate spaced slots as buttonholes and a double button to snugly secure the waistband of the non-maternity pants around a user's abdomen and using a flexible fabric garment to cover the zipper opening and, if desired, other selected portions of the abdomen of the user.
... |
| Diagnosis of preeclampsia | 20100227342 | 20100909 |
| The present invention provides methods and compositions related to the detection and/or monitoring of the levels of angiogenic factors, specifically VEGF, PlGF and sFlt-1, in urine samples obtained from pregnant women and the effects of such levels on the risk of developing complications of pregnancy, including hypertensive disorders such as preeclampsia, in the first, second, and/or third trimester of pregnancy. The present invention also provides kits for identifying and screening patients at risk of developing a complication of pregnancy, such as preeclampsia.
... |
| Prevention and treatment of osteochondrosis in animals and humans | 20100226900 | 20100909 |
| The invention provides compositions and methods for preventing and treating osteochondrosis and lameness by administration of supplemental boron containing compounds to animals and humans. The supplemental boron containing compounds are provided in animal feed compositions or as supplements for animal feed. Also provided by this invention are animal feed compositions that are supplemented with boron containing compounds and which have reduced phosphorus content. The invention also provides a method for decreasing the amount of phosphorus excreted by an animal, a method of increasing the efficiency of absorption of phosphorus by an animal, a method of reducing environmental phosphorus pollution by administering supplemental boron to the animal. The invention also provides a method of reducing pre-weaning mortality in an animal by feeding pregnant, nursing or lactating animals... |
| Apparatus and method to position a patient for airway management and endotracheal intubation | 20100218316 | 20100902 |
| An apparatus and method for properly positioning a patient to allow rapid and effective endotracheal intubation during an anesthetic induction is disclosed. The apparatus includes a plurality of inflatable sections for supporting the patient's head and upper back, where the inflatable sections are independently inflatable and deflatable with respect to one another so that the patient's ear and sternum can be aligned in the same horizontal plane. The apparatus also includes an anchoring means that is attached to at least one of the plurality of inflatable sections for anchoring the apparatus in place. An air system connected to the plurality of inflatable sections and including separate connections to the individual inflatable sections operates to provide air to the apparatus. The apparatus optionally includes an independently inflatable... |
| Method and device for non-invasive prenatal diagnosis | 20100196897 | 20100805 |
| Method for non-invasive prenatal diagnosis comprising the following steps: a. obtain a sample of an organic fluid having a high probability of containing foetal cells from a pregnant woman; b. enrich said sample of organic fluid in at least one population of cells comprising at least one type of foetal nucleated cells; c. isolate at least one cell from among said at least one type of foetal nucleated cells; d. perform a genetic analysis on said at least one cell isolated from among said at least one type of foetal nucleated cells in order to highlight at least one genetic characteristic of said at least one foetal nucleated cell suitable for permitting said diagnosis; wherein the step of isolating at least one cell from among said... |
| Biomarkers for preeclampsia | 20100190181 | 20100729 |
| The present invention relates to novel biomarkers such as histidine and ketone bodies and methods of use thereof for detecting preeclampsia in pregnant individuals and for identifying individuals at risk at an early stage of pregnancy.
... |
| Diagnosis and treatment of fertility conditions using a serine protease | 20100186101 | 20100722 |
| The invention relates to the use of a serine protease, which is specifically expressed in association with embryo implantation and placentation in pregnant uterus in the evaluation of fertility and monitoring of early pregnancy, placental development and function, fetal development, parturition, and conditions such as pre-eclampsia, intrauterine growth restriction, early abortion, abnormal uterine bleeding, endometriosis, and cancers.
... |
| Method for ammoniacal leaching | 20100180728 | 20100722 |
| In accordance with the present invention there is provided a method for leaching one or more target metals from an ore, the method comprising the method steps of: curing the ore to be leached through the application of an aqueous solution of a curing agent, producing a cured ore; leaching the cured ore at atmospheric pressure through the application of an ammonium carbonate solution containing free ammonia, producing a pregnant leach solution; and passing the pregnant leach solution to a means for metals recovery.
... |
| Method of treating pregnant cows and/or heifers | 20100178301 | 20100715 |
| The present invention relates to combination vaccines for the prophylaxis and treatment of microbiological infections in cattle which comprise an attenuated bovine viral diarrhea virus (BVDV) for the the prophylaxis and treatment of BVDV caused infections. The invention also relates to a method of vaccinating a pregnant cow.
... |
| Pregnancy testing method | 20100129935 | 20100527 |
| The present invention relates to a method of determining if a patient is pregnant and if the pregnancy is progressing. The method involves testing the patient a first time with a hCG home urine test, then after a select number of days, a second hCG home urine test is taken having a lower hCG sensitivity than the first.
... |
| Process for extracting gold from gold-bearing ore | 20100116092 | 20100513 |
| A process for extracting gold from a gold-bearing ore. The process includes, first, providing a leaching liquor with thiosulfate anion and ethylenediamine. Next, the leaching liquor is contacted with the gold-bearing ore to form a pregnant leach solution including gold dissolved from the gold-bearing ore. Finally, at least part of the gold in the pregnant leach solution is recovered.
... |
| Nucleic acid-based tests for prenatal gender determination | 20090317817 | 20091224 |
| Provided herein are compositions, processes and kits for noninvasive, early determination of fetal sex from, and/or amount of fetal nucleic acid in, an extracellular nucleic acid sample from a pregnant female. Such compositions, processes and kits are useful for detection of low genomic copy numbers of male fetal nucleic acid in a high copy number background of female nucleic acid, thereby determining the sex of a fetus and/or amount of fetal nucleic acid in a sample.
... |
| Pregnancy support cushion | 20090313760 | 20091224 |
| A support cushion for supporting a person (e.g. a pregnant woman) lying on their side includes a first cushion part configured to support the person's back, a second cushion part spaced-apart from the first cushion part and configured to support the front of the person's abdomen and/or the person's legs, and a connecting part that connects the first cushion part to the second cushion part, the connecting part configured to extend under the person's side. The first and second cushion parts may be elongate and generally in the form of cylinders, and the connecting part may be in the form of a flexible cushioned panel. The second cushion part may support a pregnant woman's swollen abdomen and may extend between, and support, her legs.
... |
| Chorionic villus sampling catheter | 20090306540 | 20091210 |
| A catheter with a guide wire and handle is provided for sampling an area of interest, such as chorionic villi. The catheter contains a cannula of flexible plastic that is non-pyrogenic and latex-free, and a flexible obturator with an elongate cylindrical handle. The cannula is echogenic and can be easily visualized with visualization or imaging device. In an embodiment, the catheter may be curved manually by the operator to conform to the patient's anatomy and it is inserted through the cervix into a pregnant uterus at 10-13 weeks gestation and placed into the developing placenta under ultrasound guidance and a guide mechanism provided on the handle. In this embodiment, once the catheter has been placed, the obturator is withdrawn and a sample of chorionic villi is... |
| Use of non-digestable sacharides for giving an infant the best start after birth | 20090305996 | 20091210 |
| A food or supplement for pregnant women comprising water soluble, non-digestible saccharides is described. The composition is used to improve the flora and/or immune system of the pregnant women, to improve the immune system of the infant and to improve the intestinal flora of the infant after birth.
... |
| Methods of enriching fetal cells | 20090305236 | 20091210 |
| The present invention relates to methods of enriching fetal cells from a pregnant female. The present invention relates to removing, from a sample, cells that comprise at least one MHC molecule. The present invention also relates to methods that rely on using telomerase, mRNA encoding components thereof, as well as telomere length, as markers for fetal cells. Enriched fetal cells can be used in a variety of procedures including, detection of a trait of interest such as a disease trait, or a genetic predisposition thereto, gender typing and parentage testing.
... |
| Method for preparing an organ for transplantation | 20090304639 | 20091210 |
| The present invention provides a means for achieving generation of a complex organ such as kidney and the like through the use of hMSCs to generate the human organ. The method for preparing a desired organ for transplantation to human by transplanting an isolated human mesenchymal stem cell to the embryo of a pregnant mammal host to induce differentiation of the mesenchymal stem cell is a method wherein the mesenchymal stem cell is transplanted into the embryo at a corresponding site for differentiation into the desired organ in the host at a transplantation time when the host is still at an immunologically tolerant stage.
... |
| Diagnostic assay and method of treatment for miscarriage risk or premature birth involving macrophage inhibitory cytokine-1 (mic-1) | 20090291889 | 20091126 |
| Methods for diagnosing risk of miscarriage and/or premature birth, foetal abnormalities, cancer (e.g. prostate cancer) and inflammatory disease (e.g. rheumatoid arthritis) are disclosed which involve determining abnormal levels of macrophage inhibitory cytokine-1 (MIC-1) in a body sample or, otherwise, determining the presence of a MIC-1 variant protein. Also disclosed are methods for reducing the risk of miscarriage and/or premature birth in pregnant subjects, and methods for treatment of inflammatory disease and/or cancer.
... |
| High coking value pitch | 20090288983 | 20091126 |
| A high coking value pitch prepared from coal tar distillate and has a low softening point and a high carbon value while containing substantially no quinoline insolubles is disclosed. The pitch can be used as an impregnant or binder for producing carbon and graphite articles.
... |
| Plant materials extraction method | 20090283473 | 20091119 |
| A process for preparing plant extracts is provided. Plant materials, including tropolones, lignins and polar molecules, are mixed with a liquid polar solvent to form an extraction mixture, which is maintained under extraction conditions effective to extract lignins, polar molecules and at least 50% of the tropolones into the polar solvent to form a pregnant polar solvent liquid phase. The pregnant polar solvent phase is separated from the solid plant materials, and mixed with a substantially immiscible nonpolar solvent under conditions effective to partition the tropolones and lignins substantially into the nonpolar solvent and to partition the polar molecules substantially into the polar solvent to form a partitioned nonpolar solvent phase comprising lignins and tropolones, and a partitioned polar solvent phase comprising the polar molecules, and... |
| Apparatus for collecting the amniotic fluid from the uterus | 20090281456 | 20091112 |
| An apparatus is provided for collecting amniotic fluid from the uterus. In order to collect the amniotic fluid from the uterus through the external orifice of the cervix of a pregnant woman, an amniotic fluid collecting unit is adapted to bring a mouth, which is foldably formed at the upper end of an amniotic fluid collecting bag, into close contact with an end of the external orifice of the cervix. Thereby, the apparatus not only significantly decreases the risk occurring when a needle is directly inserted into the uterus in order to carry out the amniocentesis (amniotic fluid testing), but also eliminates pain and anxiety caused by the direct insertion of the needle.
... |
| Non-invasive method for diagnosing fetal cells and cancer cells | 20090280496 | 20091112 |
| A non-invasive method for determining the developmental age of a fetus or detecting cancer cells in a sample is provided. The method utilizes, for example, a sample of blood from a pregnant female and telomeric nucleic acid probes.
... |
| Apparatus for collecting the amniotic fluid from the uterus | 20090281456 | 20091112 |
| An apparatus is provided for collecting amniotic fluid from the uterus. In order to collect the amniotic fluid from the uterus through the external orifice of the cervix of a pregnant woman, an amniotic fluid collecting unit is adapted to bring a mouth, which is foldably formed at the upper end of an amniotic fluid collecting bag, into close contact with an end of the external orifice of the cervix. Thereby, the apparatus not only significantly decreases the risk occurring when a needle is directly inserted into the uterus in order to carry out the amniocentesis (amniotic fluid testing), but also eliminates pain and anxiety caused by the direct insertion of the needle.
... |
| Non-invasive method for diagnosing fetal cells and cancer cells | 20090280496 | 20091112 |
| A non-invasive method for determining the developmental age of a fetus or detecting cancer cells in a sample is provided. The method utilizes, for example, a sample of blood from a pregnant female and telomeric nucleic acid probes.
... |
| Metal extraction without cyanide | 20090272227 | 20091105 |
| An improved process and composition for the extraction of metal from a metal-laden ore, soil or rock is provided. A liquid, three-component aqueous lixiviant comprises water, an alkali metal salt and a low pH acidic composition. A four-component aqueous lixiviant comprises water, a low pH acidic composition, an alkali metal salt and an acid having a pH value less than 2. Both lixiviant compositions are efficient for extracting metal into a pregnant liquid solution. The pregnant solution is treated by known conventional means, such as filtration, centrifuging or electrolysis to remove the extracted metals. The three-component and four-component aqueous lixiviants of the present invention are non-toxic, meaning, not an irritant or deleterious to humans or the environment and perform, as well as, or better than known... |
| Metal extraction without cyanide | 20090272227 | 20091105 |
| An improved process and composition for the extraction of metal from a metal-laden ore, soil or rock is provided. A liquid, three-component aqueous lixiviant comprises water, an alkali metal salt and a low pH acidic composition. A four-component aqueous lixiviant comprises water, a low pH acidic composition, an alkali metal salt and an acid having a pH value less than 2. Both lixiviant compositions are efficient for extracting metal into a pregnant liquid solution. The pregnant solution is treated by known conventional means, such as filtration, centrifuging or electrolysis to remove the extracted metals. The three-component and four-component aqueous lixiviants of the present invention are non-toxic, meaning, not an irritant or deleterious to humans or the environment and perform, as well as, or better than known... |
| Fetal movement information processing device and fetal movement information processing method | 20090270767 | 20091029 |
| A fetal movement information processing device and method for accurately grasping and predicting the healthy development state of a fetus, namely, the well-being state of the fetus by adequately detecting and recording information on the fetal movement of a pregnant woman. The fetal movement information processing device comprises detected information storage means (20) for storing fetal movement detection signal detected by a fetal movement sensor (11) and detection day information associated with the fetal movement detection signal, pregnancy number-of-elapsed-days calculating means (38) for calculating the number of elapsed days from the fetal movement detection signals, fetal movement amount measuring means (54) for measuring the fetal movement amount per unit time from fetal movement signals read out from the detected information storage means, and displaying/outputting means (60)... |
| Fetal movement information processing device and fetal movement information processing method | 20090270767 | 20091029 |
| A fetal movement information processing device and method for accurately grasping and predicting the healthy development state of a fetus, namely, the well-being state of the fetus by adequately detecting and recording information on the fetal movement of a pregnant woman. The fetal movement information processing device comprises detected information storage means (20) for storing fetal movement detection signal detected by a fetal movement sensor (11) and detection day information associated with the fetal movement detection signal, pregnancy number-of-elapsed-days calculating means (38) for calculating the number of elapsed days from the fetal movement detection signals, fetal movement amount measuring means (54) for measuring the fetal movement amount per unit time from fetal movement signals read out from the detected information storage means, and displaying/outputting means (60)... |
| Progesterone for the treatment or prevention of spontaneous preterm birth | 20090264395 | 20091022 |
| A method for treating or preventing spontaneous preterm birth in pregnant women and improving neonatal morbidity and mortality. The method includes administering to a pregnant woman in need thereof an effective amount of progesterone sufficient to prolong gestation by minimizing the shortening or effacing of her cervix. Treatment and prophylaxis with progesterone in pregnant women having symptoms of short cervix has been clinically shown to increase neonatal health.
... |
| Agents containing folic acid, vitamin b6 and vitamin b12, and the use thereof | 20090253649 | 20091008 |
| (EN) The invention relates to agents that contain folic acid, vitamin B6 and vitamin B12. and to the use thereof in hyperhomocysteinemia for controlling homocysteine levels. The agents are mainly suitable for the preventive and acute treatment of vascular diseases, of pregnant women and neurodegenerative diseases and are particularly advantageous in cases where the homocysteine levels to be controlled are found in an individual suffering from renal failure or being treated with immune suppressors. The invention particularly relates to pharmaceutical agents and food supplements comprising a corresponding active ingredient combination and to agents in the form of commercial packages containing corresponding combination preparations or monopreparations for the combined use.
... |
| Agents containing folic acid, vitamin b6 and vitamin b12, and the use thereof | 20090253649 | 20091008 |
| (EN) The invention relates to agents that contain folic acid, vitamin B6 and vitamin B12. and to the use thereof in hyperhomocysteinemia for controlling homocysteine levels. The agents are mainly suitable for the preventive and acute treatment of vascular diseases, of pregnant women and neurodegenerative diseases and are particularly advantageous in cases where the homocysteine levels to be controlled are found in an individual suffering from renal failure or being treated with immune suppressors. The invention particularly relates to pharmaceutical agents and food supplements comprising a corresponding active ingredient combination and to agents in the form of commercial packages containing corresponding combination preparations or monopreparations for the combined use.
... |
| Prosthetic apparatus and method | 20090240345 | 20090924 |
| An apparatus and method for fitting a person with a maternity garment includes one or more prosthetic devices. Each prosthetic device simulates a belly enlarged by a corresponding stage of pregnancy, to be worn by a person while wearing the maternity garment to simulate the fit and appearance of the maternity garment being worn by a pregnant person.
... |
| Reducing/oxidizing activity of maternal urine as indicator of fetal gender related characteristics | 20090233321 | 20090917 |
| The present invention provides a method for determining the gender of an unborn child by assaying the overall reducing/oxidizing or redox activity of the maternal urine or other body fluid. The method can be used to determine fetal gender at any time point during the entire pregnancy, the earliest being the first day of a missed menstruation. The body fluid may be processed before assaying. Processing may involve aging the body fluid, or purification of various fractions. The methods of the present invention also provide for a means for pre-conception baby gender planning by assaying the overall redox activity of a non-pregnant female's urine or other body fluid. The overall redox activity of a urine sample correlates with the gender specific compatibility of the ovum being... |
| Disposable nursing pad with non-slippage backing | 20090234315 | 20090917 |
| b) inner absorbent layer means disposed on an inner section of the outer layer means in contact with the breast to absorb leaking secreted fluids; wherein the inner absorbent layer is a multi-functional pressure sensitive adhesive that is moisture absorbing, and moisture transmitting.
... |
| Method of delivery of nucleic acids to a developing embryo | 20090235373 | 20090917 |
| Methods to introduce genetic material, such as DNA, to embryos, are disclosed. In some embodiments, the method involves preparing the pregnant mother to receive the genetic material into a blood transport vessel which passes to the embryo, avoiding a maternal capillary bed and introducing the material under low pressure so as not to kill the pregnant animal. The effectiveness of the method is such that the nucleic acid has been expressed in all the cells of the embryo and in the postnatal mouse, including the primordial germ cells, thus making the nucleic acid germ line heritable.
... |
| Reducing/oxidizing activity of maternal urine as indicator of fetal gender related characteristics | 20090233321 | 20090917 |
| The present invention provides a method for determining the gender of an unborn child by assaying the overall reducing/oxidizing or redox activity of the maternal urine or other body fluid. The method can be used to determine fetal gender at any time point during the entire pregnancy, the earliest being the first day of a missed menstruation. The body fluid may be processed before assaying. Processing may involve aging the body fluid, or purification of various fractions. The methods of the present invention also provide for a means for pre-conception baby gender planning by assaying the overall redox activity of a non-pregnant female's urine or other body fluid. The overall redox activity of a urine sample correlates with the gender specific compatibility of the ovum being... |
| Disposable nursing pad with non-slippage backing | 20090234315 | 20090917 |
| b) inner absorbent layer means disposed on an inner section of the outer layer means in contact with the breast to absorb leaking secreted fluids; wherein the inner absorbent layer is a multi-functional pressure sensitive adhesive that is moisture absorbing, and moisture transmitting.
... |
| Method of delivery of nucleic acids to a developing embryo | 20090235373 | 20090917 |
| Methods to introduce genetic material, such as DNA, to embryos, are disclosed. In some embodiments, the method involves preparing the pregnant mother to receive the genetic material into a blood transport vessel which passes to the embryo, avoiding a maternal capillary bed and introducing the material under low pressure so as not to kill the pregnant animal. The effectiveness of the method is such that the nucleic acid has been expressed in all the cells of the embryo and in the postnatal mouse, including the primordial germ cells, thus making the nucleic acid germ line heritable.
... |
| Method of diagnosis of pregnancy-related complications | 20090227036 | 20090910 |
| A method for diagnosing pregnancy-related complications in a pregnant woman is provided. The method includes (a) providing a membrane phospholipid suspension; (b) exposing a first portion of the suspension to standard PP13; (c) exposing a second portion of the suspension to PP13 obtained from the woman; (d) measuring the production of prostaglandins in (b) and (c); and (e) comparing the amounts of prostaglandins produced in (b) and (c), a change in the amount of prostaglandins of (c) as compared to the amount of prostaglandins in (b) indicating the existence of a pregnancy-related complication in the woman.
... |
| Filtration media for the removal of basic molecular contaminants for use in a clean environment | 20090211453 | 20090827 |
| Novel acid-impregnated silica materials for use as environmental controls in air handling systems where highly efficient removal of ammonia and volatile amines from gaseous streams is required (e.g. clean rooms) are provided. Such silicas exhibit specific porosity and density measurements to provide a satisfactory support for an acid impregnant incorporated subsequent to initial solid silica particle production, in order to provide effective ammonia bonding sites. The combination of the silica support properties and the acid impregnant permits highly effective ammonia (or volatile amine) gas removal, resulting in excellent noxious gas removal efficiencies and capacities, particularly in comparison with prior media filtration products. Methods of using such acid-impregnated silica filter media and specific filter apparatuses are also encompassed within this invention.
... |
| Prevention and treatment of osteochondrosis in animals and humans | 20090214500 | 20090827 |
| The present invention relates to compositions and methods for preventing and treating osteochondrosis by administration of supplemental boron containing compounds to animals and humans. The supplemental boron containing compounds are provided in animal feed compositions or as supplements for animal feed. Also provided by this invention are animal feed compositions that are supplemented with boron containing compounds and which have reduced phosphorus content. The invention also provides a method for treating or preventing osteochondrosis in animals or humans by the administration of supplemental boron containing compounds. The invention also provides a method for decreasing the amount of phosphorus excreted by an animal, a method of increasing the efficiency of absorption of phosphorus by an animal, a method of reducing environmental phosphorus pollution by administering supplemental boron... |
| Use of antagonist of oxytocin and/or vasopressin in assisted reproduction | 20080318847 | 20081225 |
| The present invention relates to the use of antagonists of oxytocin, antagonists of oxytocin and vasopressin, or antagonists of vasopressin, or their pharmaceutically accepted salts, or their combinations with other drugs for the manufacture of a medicament which main profile of action is inhibition of oxytocin and/or vasopressin receptors in non-pregnant uterus of mammals, that results in improvement of uterine receptivity in embryo transfer. It further relates to the application of these substances for the manufacture of a medicament for regulating the uterine contractile activity in cases of artificial insemination.
... |
| Activity monitoring system for pregnant women | 20080319353 | 20081225 |
| An activity feedback system for an individual is disclosed. The activity feedback system can be wearable by the individual and provide activity information and possibly other information to the individual. The individual can, for example, be a pregnant woman. The activity information can, for example, be used by a pregnant woman to monitor the amount of activity by the woman during as well as after her pregnancy. Besides activity information, the activity feedback system can also monitor, record or provide other information that is beneficial for individuals.
... |
| Cervical dilator catheter | 20080319472 | 20081225 |
| This invention is an improved balloon catheter for cervical dilation. This catheter has a balloon that is passed through the cervix of a pregnant woman, and the balloon is then inflated with 100-120 ml of sterile water or normal saline. The improved disc shape of the inflated balloon is 8 cm in diameter and 3-4 cm in height. The balloon will sweep the amniotic membrane away from the cervix, causing the release of prostaglandins which helps ripen the cervix and initiates uterine contractions. The improved shape of the balloon causes the cervix to be 6-8 cm dilated once it is expelled. This catheter also contains a flexible guidewire that allows for easier insertion for the provider, and makes insertion less painful for the patient because it... |
| Diagnostic test for inflammatory endothelial dysfunctions in pregnancies | 20080311603 | 20081218 |
| The present invention relates to a diagnostic test for inflammatory endothelial dysfunctions in pregnant women. Particularly, the present invention relates to a method of diagnosing or evaluating the risk of contracting an inflammatory endothelial dysfunction of the maternal compartment comprising the following steps: a) detecting the plasma levels of long pentraxin PTX3 in blood samples taken from a pregnant woman; b) comparing the PTX3 plasma level data, obtained according to step a), with statistically significant PTX3 plasma level data of normal pregnant population.
... |
| Sequential lixivation and precipitation of metals from refractory ores by utilising variable oxidation reduction potentials and a variable ph system | 20080302671 | 20081211 |
| This invention relates to an improved electrochemical process for winning platinum group and incidental precious metals from ore. The process utilizes a peroxide leach in combination with electricity to produce higher valency metals and comprises the following steps: combining ground ore with a solution comprising water with a selected amount of H2O2 and an anion source to form a slurry; applying a direct current while allowing the metal in the ore to leach into the solution for a selected period of time; filtering and clarifying the leached slurry to obtain a pregnant solution; and treating the pregnant solution to yield metal, metal salts or both.
... |
| Method of measuring cancer aggressiveness and detection thereof | 20080305513 | 20081211 |
| Erythrocyte sedimentation rate (“ESR”) determinations of a patient's blood that has been combined either with blood serum from pregnant mammals or with fetal embryonic serum yield measurable results correlating well with the presence of an on-going cancer. This cancer detection method is based on differential ESR determinations and uses paired in vitro ESR tests, in which a patient's whole blood is combined with a control serum (in a control vial) comprising serum from non-pregnant mammal and with a test serum (in a test vial) comprising either fetal embryonic serum or serum from a pregnant mammal to measure differential ESR in the tested control vials. Cancer coefficient K is calculated based on the ESR measurements and is compared with a threshold value to determine whether the patient... |
| Process for leaching lateritic ore at atmospheric pressure | 20080271571 | 20081106 |
| An atmospheric leaching process in the recovery of nickel and cobalt from a lateritic ore, the lateritic ore including a low magnesium ore fraction and a high magnesium ore fraction, the process including the steps of: (a) forming an aqueous pulp of the lateritic ore, (b) leaching the aqueous pulp with a concentrated mineral acid at atmospheric pressure to produce a slutty containing a pregnant leach liquor and a leach residue, (c) treating the pregnant leach liquor either separately or as part of the slurry to recover dissolved nickel and cobalt therefrom, leaving a magnesium barren solution, (d) treating the magnesium containing solution to recover a magnesium containing salt therefrom.
... |
| Neural tube birth defect reduction with folic acid delivery in catamenial hygiene products | 20080254098 | 20081016 |
| A method and apparatus of fortifying a population of fertile age women with folic acid to reduce the incidence of neural tube birth defects involves placing folic acid either in powder, microcapsule, gel, cream, tablet, capsule or other form in or on a feminine hygiene product such as a tampon or a menstrual pad and making such products available to the population of women so that their normal use of the tampons or other feminine hygiene products will result in absorption of a sufficient amount of folic acid to satisfy RDA requirements for women who may or have become pregnant. In certain embodiments, vitamin B12 and/or other nutrients or ingredients are added to the folic acid vehicle.
... |
| Compositions and methods for nutrition supplementation | 20080254142 | 20081016 |
| The present invention relates to compositions comprising various vitamins and minerals and methods for using these compositions for nutritional supplementation in, for example, pregnant or lactating subjects.
... |
| Methods and kits for predicting risk for preterm labor | 20080254479 | 20081016 |
| The invention is directed to kits and methods that allow one to predict the risk for preterm labor in a pregnant woman. The inventors have discovered that various extracellular matrix components can be detected in cervical secretions. The quantification of certain extracellular matrix proteins found within cervical secretions can be used as a diagnostic for the biomechanical state of the cervix, which indicates whether preterm labor is likely. Some extracellular matrix components that can be found in cervical secretions include hyaluronic acid, thrombospondins and matrix metalloproteinases.
... |
| Copolymer of styrene and maleic anhydride comprising an epoxy resin composition and co-cross linking agent | 20080255306 | 20081016 |
| A composition useful as an impregnant for the making of laminates for printed wiring boards comprises a FR4 epoxy resin which is a bisphenol A epoxy resin advanced with tetrabromobisphenol A, a crosslinking agent of a strene-maleic anhydride copolymer and a co-crosslinking agent is an optionally brominated bisphenol A and/or an optionally brominated bisphenol A diglycidyl ether.
... |
| Compositions and methods for nutrition supplementation | 20080248132 | 20081009 |
| The present invention relates to compositions comprising various vitamins and minerals and methods for using these compositions for nutritional supplementation in, for example, pregnant or lactating subjects.
... |
| Compositions and methods for nutrition supplementation | 20080248133 | 20081009 |
| The present invention relates to compositions comprising various vitamins and minerals and methods for using these compositions for nutritional supplementation in, for example, pregnant or lactating subjects.
... |
| Apparatus for transmitting sound to a fetus | 20080219468 | 20080911 |
| An apparatus for delivering sound to a fetus through a pregnant woman's abdomen. In a preferred embodiment, the apparatus utilizes limited-volume, modular sound transmitters encased in housings which are affixed on their undersides with a compound that safety adheres each transmitter to any appropriate location on the outer wall of the abdomen. The transmitters and their respective housings are connected to each other electronically at one end by an audio plug, not unlike commercial headphones, where is situated an additional audio jack meant for the purpose of simultaneous listening. An external case holds the housings together when not in use thereby protecting the adhesive compound from the elements. Alternatively, the apparatus may include shells adapted to receive commercially available sound transmitters such as ear buds.
... |
| Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy | 20080207543 | 20080828 |
| The intramuscular electroporated injection of a protease-resistant growth hormone-releasing hormone (“GHRH”) cDNA into rat dams at 16 days of gestation resulted in the enhanced long-term growth of the FI offspring. The offspring were significantly heavier by one week of age and the difference was sustained to 10 weeks of age. Consistent with their augmented growth, plasma IGF-I concentration of the FI progeny was increased significantly. The pituitary gland of the offspring was significantly heavier, and contained an increased number of somatotropes (cells producing GH) and lactotrophs (prolactin-secreting cells), and is indicative of an alteration in cell lineages. These unique findings demonstrate that enhanced GHRH expression in pregnant dams can result in intergenerational growth promotion, by altering development of the pituitary gland in the offspring.
... |
| Human milk fortifiers and methods for their production | 20080187619 | 20080807 |
| The present invention relates to a human milk fortifier as well as to several uses and a method for the production of such a fortifier. A particularly beneficial fortifier can be realised in that at least one human component based on a product directly or indirectly derived from human mammary secretion during non-pregnant, pregnant, lactating and/or involuting periods is used, giving rise to an optimally adapted fortifying effect which is particularly useful in the context of feeding preterm infants.
... |
| Progesterone for the treatment or prevention of spontaneous preterm birth | 20080188829 | 20080807 |
| A method for treating or preventing spontaneous preterm birth in pregnant women and improving neonatal morbidity and mortality. The method includes administering to a pregnant woman in need thereof an effective amount of progesterone sufficient to prolong gestation by minimizing the shortening or effacing of her cervix. Treatment and prophylaxis with progesterone in pregnant women having symptoms of short cervix has been clinically shown to increase neonatal health.
... |
| Non-invasive method for isolation and detection of fetal dna | 20080182261 | 20080731 |
| A method of detecting the presence or absence of the fetal DNA sequence of interest in fetal DNA derived from a sample of peripheral blood obtained from a pregnant woman is described. The method involves obtaining a sample peripheral blood from a pregnant woman, treating the sample of peripheral blood such that the fetal DNA present in the fetal nucleated cells is made available for detection and detecting the presence or absence of the fetal DNA sequence of interest in the available fetal DNA. The proportion of fetal nucleated cells present in the sample of peripheral blood can be increased forming a sample enriched in fetal nucleated cells prior to the detection step. The fetal DNA sequence of interest can be detected by treating the peripheral... |
| Apparatus for monitoring fetal heart-beat | 20080183092 | 20080731 |
| Apparatus for monitoring a fetal heart-beat is able to extract one or more fetal electrocardiograms (fECGs) from a composite signal detected at the abdomen of a pregnant woman. The apparatus includes specific low-noise components: a plurality of low-noise electrodes (1-3, R) for placement on the abdomen during pregnancy and a low-noise signal recording and processing means (34). Screened leads are also used, as required. Signals indicative of voltages developed between each abdominal electrode (1-3) and a reference electrode (R) are recorded in a plurality of signal channels. Data within each channel is digitised and processed in order to generate a plurality of separated source signals, at least one of which relates to the fECG of a single fetus. Single-channel fECGs may be reconstructed using the source... |
| Markers and methods for prenatal of chromosal alberrations | 20080166708 | 20080710 |
| The invention concerns prenatal screening of chromosomal aberrations, more particularly, through identification of novel markers of chromosomal aberrations, in particular, trisomy 21, whereof the assay based on a body fluid of the pregnant woman enables, alone or in combination with other assays, the probability that the fetus suffers from a chromosomal aberration to be more accurately determined than that by currently used tests.
... |
| Method for recovering metal values from metal-containing materials using high temperature pressure leaching | 20080156656 | 20080703 |
| The present invention relates generally to a process for recovering copper and other metal values from metal-containing materials through pressure leaching operations. In accordance with the various aspects of the present invention, metal-containing pregnant leach solutions from pressure leaching operations need not be significantly diluted to facilitate effective metal recovery using solvent extraction and electrowinning.
... |
| A combined uterine activity and fetal heart rate monitoring device | 20080161689 | 20080703 |
| A combinational fetal heart rate monitor and uterine activity measuring device for use on a pregnant patient. The fetal heart rate and uterine activity monitor comprising a plurality of electrodes disposed to be attached on the abdomen of the patient and an ultrasound transducers disposed to be attached on the abdomen of the patient. An energy source is operable to generate an excitation signal and the energy source is connected to a multiplexer which is connected between the plurality of electrodes and the ultrasound transducer, the multiplexer being selectively positioned to direct the excitation signal from the energy source to either the electrode or the ultrasound transducer. An amplifier connected to the energy source compares the excitation signal to the excitation signal after it passes through... |
| Circulating mrna as diagnostic markers | 20080153090 | 20080626 |
| Methods and kits are provided for diagnosing, monitoring, or predicting the conditions of pre-eclaimpsia, fetal chromosomal aneuploidy, and pre-term labor in a pregnant woman, as well as for detecting pregnancy in a woman, by quantitatively measuring in the maternal blood the amount of one or more mRNA species encoding human chorionic gonadotropin β subunit (hCG-β), human placental lactogen (hPL), human corticotropin releasing hormone (hCRH), KiSS-1 metastasis-suppressor (KISS1), tissue factor pathway inhibitor 2 (TPFI2), placenta-specific 1 (PLAC1), or glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and comparing the amount of the mRNA species with a standard control.
... |
| Fetal physiology during maternal surgery or diagnosis | 20080153920 | 20080626 |
| The occurrence of hypercapneic acidosis in a fetus during a laparoscopic procedure carried out on a pregnant female, is prevented or ameliorated by inclusion in or addition to the carbon dioxide insufflation gas, of a nitric oxide donor, e.g., ethyl nitrite. Administration of nitric oxide donor in insufflation gas causes increase in fetal cerebral oxygenation.
... |
| Agents containing folic acid, vitamin b6 and vitamin b12, and the use thereof | 20080139498 | 20080612 |
| (EN) The invention relates to agents that contain folic acid, vitamin B6 and vitamin B12. and to the use thereof in hyperhomocysteinemia for controlling homocysteine levels. The agents are mainly suitable for the preventive and acute treatment of vascular diseases, of pregnant women and neurodegenerative diseases and are particularly advantageous in cases where the homocysteine levels to be controlled are found in an individual suffering from renal failure or being treated with immune suppressors. The invention particularly relates to pharmaceutical agents and food supplements comprising a corresponding active ingredient combination and to agents in the form of commercial packages containing corresponding combination preparations or monopreparations for the combined use.
... |
| Method for determining the effectiveness of a treatment for preeclampsia | 20080131867 | 20080605 |
| A method for determining the effectiveness of a treatment for preeclampsia of a pregnant woman at risk for preeclampsia, the method comprising: (a) determining a first concentration of placental protein 13 (PP13) in a bodily substance of the woman obtained prior to the treatment; (b) determining a second concentration of PP13 in a bodily substance of the woman obtained after initiation of the treatment; and (c) comparing the first and second concentrations to a corresponding normal level of PP13 and, based on the comparison, determining the effectiveness of the treatment. Diagnostic kits for practicing the method are also disclosed.
... |
| Blind adaptive filter extraction of fetal electrocardiogram signal estimate | 20080125668 | 20080529 |
| A blind adaptive filter of an apparatus in an example employs a frequency domain ECG-feature vector and a time domain ECG feature vector with a maternal ECG parameter estimate and a set of candidate fetal ECG estimates that satisfy the frequency domain ECG-feature-vector, to extract a fetal ECG signal estimate from raw abdominal ECG signals of a pregnant female. The fetal ECG signal estimate satisfies the frequency domain ECG feature-vector and the time domain ECG feature vector.
... |
| Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin | 20080108045 | 20080508 |
| A method of preparing an amniotic membrane extract including the steps of obtaining a healthy amniotic membrane from a pregnant mammal, such as a pig, cow, horse or human, homogenizing the membrane to obtain a homogenate solution, freezing the homogenate solution, and lyophilizing the frozen homogenate solution to dryness is disclosed. Preferably, the lyophilized homogenate is pulverized to a powder. The lyophilized homogenate is then reconstituted before use, e.g., in a liquid, such as a balanced salt solution or fresh amniotic fluid, or in another substance, such a gel, an ointment, a cream or a soap, depending on the intended use. Also disclosed is a pharmaceutical composition prepared according to the method of the invention, for prophylaxis and/or treatment of a disease or condition, especially of... |
| Apparatus and method for controlled deployment of shape-conforming materials | 20080087431 | 20080417 |
| An apparatus and method for filling a defined space, such as an annulus around a production tubular within a wellbore, includes a compliant porous material. The compliant porous material can be compressed and maintained in a compressed state by incorporation of a deployment modifier, which may be a water-soluble or oil-soluble adhesive or biopolymer, used as an impregnant, a coating, or a casing. The production tubular can be positioned at a desired location and the compliant porous material exposed to a deployment modifier neutralizing agent, which then dissolves or otherwise prevents the deployment modifier from continuing to inhibit deployment. Thus, deployment can be delayed to an optimum time by preventing exposure of the deployment modifier to the deployment modifier neutralizing agent. It is emphasized that this... |
| Methods and kits for predicting risk for preterm labor | 20080090759 | 20080417 |
| The invention is directed to kits and methods that allow one to predict the risk for preterm labor in a pregnant woman. The inventors have discovered that various extracellular matrix components can be detected in cervical secretions. The quantification of certain extracellular matrix proteins found within cervical secretions can be used as a diagnostic for the biomechanical state of the cervix, which indicates whether preterm labor is likely. Some extracellular matrix components that can be found in cervical secretions include decorin, thrombospondins and matrix metalloproteinases.
... |
| Tobacco smoke filter | 20070295346 | 20071227 |
| A tobacco smoke filter containing a high activity activated carbon impregnated with a metal impregnant. The use of a relatively low level of impregnant, in combination with a base carbon having higher activity than that use in standard cigarette filters, is highly effective in removing HCN from cigarette smoke.
... |
| Method for treating preeclampsia | 20070292421 | 20071220 |
| Disclosed are methods and compositions for treating or inhibiting the onset of preeclampsia through administration to a pregnant mammal in need of such a treatment an effective amount of at least one C5a inhibitor. The C5a inhibitor may be co-administered with other active agents.
... |
| Pregnancy test device | 20070292969 | 20071220 |
| A pregnancy test device aids a woman in determining whether or not she is pregnant. The pregnancy test device includes a molded body, having a series of apertures and a display window; a sample pad, disposed within the molded body for receiving a urine sample, said sample pad treated to detect the presence of human chorionic gonadotropin or its β-subunit, and exposed through the series of apertures in the molded body; a membrane, operatively connected to the sample pad, to display the results of the pregnancy test, and said membrane positioned to be viewed through the display window of the molded body; and gold, disposed between the sample pad and the membrane.
... |
| Ultrasonic moving-picture real-time service system and method and recording medium having embodied thereon computer program for performing method | 20070282201 | 20071206 |
| Disclosed herein are an ultrasonic moving-picture real-time service system and method and a recording medium having embodied thereon a computer program for performing the method and, more particularly, to an ultrasonic moving-picture real-time service system and method and a recording medium having embodied thereon a computer program for performing the method, which can allow the family of a pregnant woman to view an ultrasonic moving picture in real time over an Internet network while the pregnant woman receives a medical treatment using ultrasonic waves in a hospital and can automatically log in to a central server of the hospital and stream or download an ultrasonic moving picture of the pregnant woman when a compact disc (CD), which receives from the hospital and stores basic contents and... |
| Copolymer of styrene and maleic anhydride comprising an epoxy resin composition and a co-cross linking agent | 20070275250 | 20071129 |
| A composition useful as an impregnant for the making of laminates for printed wiring boards including an epoxy resin a first cross-linking agent of a strene-maleic anhydride copolymer and a second co-cross-linking agent.
... |
| Clinical thermometer capable of recording and analyzing the day of getting pregnant | 20070276283 | 20071129 |
| A clinical thermometer capable of recording and analyzing the day of getting pregnant includes a casing, an LCD device, a press key unit, a body temperature detecting element for detecting a body temperature, a microprocessor for receiving a signal from the body temperature detecting element, computing the signal and displaying the body temperature by the LCD device, a flash memory connected to the microprocessor for storing data and having a partitioned memory block for storing an Auto Run program, and a power supply unit electrically connected to the microprocessor for supplying power to components, and a USB interface installed at the casing and electrically connected to the microprocessor, such that when the USB interface is connected to a personal computer, the Auto Run program automatically sends... |
| Thiosulphate leach process | 20070266827 | 20071122 |
| An improved thiosulphate leach process for the recovery of gold from ores and other gold-bearing materials, characterised in that the leach solution comprises thiosulphate, thiourea or a reagent chemically related thereto, and an oxidant that does not oxidise thiosulphate, the process producing a pregnant leach solution from which gold may be recovered.
... |
| Disposable labor detection patch | 20070255184 | 20071101 |
| The invention provides a low cost, fully integrated, disposable patch for the non-invasive monitoring of labor contractions. The patch monitors EMG bursts present on a pregnant woman's abdomen via a set of electrodes embedded in the invented patch. The contraction monitor patch is thin, flexible, and incorporates EMG amplifiers, a processor, a battery, and an indicator within. The indicator is activated when labor EMG patterns are detected. The labor detection patch is particularly suited for women with risk of premature delivery. The patch is unobtrusively and continuously worn, even during sleep and bathing. In another embodiment, the contraction monitor patch is used in hospitals during labor and delivery to monitor the status of contractions with a wireless link to an external monitoring unit.
... |
| Bayer process for production of alumina trihydrate, the said improvement relating to separation of aluminate liquor and insoluble residues | 20070243118 | 20071018 |
| A process for the production of alumina trihydrate by alkaline digestion of bauxite using the Bayer process in which aluminate liquor and insoluble residues are separated using a solid/liquid separation device (E; W2; DC) characterised in that the said slurry (21a; 41; 230′) is at least partially passed through a hydrocyclone (H1; H21; H22; H3) to improve and accelerate the separation of the sodium aluminate liquor from the insoluble residues in the slurry (21a; 41; 230′) containing the said liquor and the said residues and that supplies or is derived from the said liquid—solid separation device. In a first embodiment, at least one hydrocyclone is used at the upstream side of the settler—thickener, as clarifier of the pregnant liquor. In a second embodiment, at least one... |
| Enrichment of circulating fetal dna | 20070243549 | 20071018 |
| A non-invasive screening or diagnostic method for determining the likelihood of a fetus with a genetic abnormality or a potential pregnancy complication, which utilizes a liquid blood sample from a pregnant woman. Antibodies specific to a section of histone 3.1 which is exposed to a far greater extent in chromatin of fetal origin than in chromatin of maternal origin are used to sequester and isolate such fetal nucleosomes including the associated fetal DNA. Following isolation/enrichment of such fetal DNA, genetic analysis is carried out using known molecular diagnostics.
... |
| Nutritional supplement for pregnant females | 20070231312 | 20071004 |
| Preeclampsia and intrauterine growth restriction in a pregnant female mammal are prevented or decreased in severity by administering thereto a combination of a vitamin compound containing B1, Folic Acid (or active form 5-Methyl-Tetrahydrofolate i.e.; Metafolin®), B 6 (Pyridoxine or active form Pyridoxine 5-Phosphate P5P), B 12, Ascorbic Acid, Selenium, Zinc, Co-enzyme Q 10 and N-Acytyl Cysteine, Lycopene, optionally in further combination with Melatonin and/or Vitamin E or/and ASA 81 mg both of later, are cyclooxygenase inhibitors, a PGI.sub.2-mimetic, a thromboxane (TXA.sub.2) inhibitor, a compound possessing TXA.sub.2-agonistic and TXA.sub.2-inhibiting properties, a compound possessing TXA.sub.2-antagonistic and PGI.sub.2-mimetic activities, and a TXA.sub.2 antagonist.
... |
| System and method for monitoring pre-eclamptic patients | 20070232938 | 20071004 |
| A system and method for monitoring and estimating the blood pressure of a pregnant patient that modifies the blood pressure estimating algorithm when the patient is pre-eclamptic. The level of carbon monoxide within a patient's bloodstream or exhaled breath can be analyzed to determine whether a pregnant patient is pre-eclamptic. After the patient has been diagnosed as pre-eclamptic, the NIBP monitoring system adjusts its algorithm for estimating the patient's blood pressure to compensate for the physical changes that occur in the patient during pre-eclampsia. The adjusted blood pressure estimates calculated by the NIBP monitoring system can be calculated using different adjustment techniques and methods and are displayed on the NIBP monitor.
... |
| Low-density ablative heat shield fabrication | 20070224407 | 20070927 |
| Spacecraft heat shields are fabricated as one-piece assemblies using low-density ablative thermal protection materials. The heat shield assembly is built from modular pieces formed by ablative impregnation processing. Once the full-size heat shield is assembled from the modular blocks, heat treatment is used to bond the individual blocks together by facilitating polymeric cross-linking of impregnant material within and/or between each block. This provides a structurally integral one-piece heat shield assembly that can be further machined to final dimensions and attached directly to a spacecraft structure or a carrier panel separately attached to the spacecraft
... |
| Isolating fetal trophoblasts | 20070224597 | 20070927 |
| Methods for isolating and purifying fetal trophoblasts from a mucus sample obtained from the uterine cavity of a pregnant female. The mucus sample is transported from a clinical collection facility to a laboratory in a transportation medium so the cells remain viable. The mucus sample is then subjected to precise processing steps, including treatment with mucolytic agents or mucinases, sugar hydrolysis enzymes, nucleases, and proteases to provide fetal cells, the outer surfaces of which are so essentially completely devoid of attached mucosal biological material that they are then isolated in greater numbers than previously had been possible. The isolated cells are in appropriate condition to immediately be effectively subjected to FISH or to other molecular diagnostics.
... |
| Callus remover with strainer | 20070214557 | 20070920 |
| This invention is a foot health care device with strainer for removing foot callus hand-free while people are taking shower. It adds the function of a rasp to a regular traditional strainer. The device has a cylinder bottom with draining holes that allow water going through, a dome-shaped upper portion with strips of ridges that functions as a rasp to effectively and efficiently remove foot callus, the supporting frames that provide support to the device, and an outside scale-like rim worked as a fine rasp to fine-tune the foot. It is good for the foot health. Since it is used hand free this feature can be extremely beneficial for those aged, disabled, pregnant, overweighed and arthritic who have difficulty bending leg or bending over. It is... |
| Plant materials extraction method | 20070219141 | 20070920 |
| A process for preparing plant extracts is provided. Plant materials, including tropolones, lignins and polar molecules, are mixed with a liquid polar solvent to form an extraction mixture, which is maintained under extraction conditions effective to extract lignins, polar molecules and at least 50% of the tropolones into the polar solvent to form a pregnant polar solvent liquid phase. The pregnant polar solvent phase is separated from the solid plant materials, and mixed with a substantially immiscible nonpolar solvent under conditions effective to partition the tropolones and lignins substantially into the nonpolar solvent and to partition the polar molecules substantially into the polar solvent to form a partitioned nonpolar solvent phase comprising lignins and tropolones, and a partitioned polar solvent phase comprising the polar molecules, and... |
| Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women | 20070212364 | 20070913 |
| The present invention relates methods for reducing the adverse effects of nicotine. This application describes the use of nicotine carrier conjugates in decreasing the toxic effects of nicotine on a fetus.
... |
| Non-invasive method for diagnosing fetal cells and cancer cells | 20070212720 | 20070913 |
| A non-invasive method for determining the developmental age of a fetus or detecting cancer cells in a sample is provided. The method utilizes, for example, a sample of blood from a pregnant female and telomeric nucleic acid probes.
... |
| Heap bioleaching process for the extraction of zinc | 20070193413 | 20070823 |
| A method of extracting zinc from a sulphidic ore is provided which comprises bioleaching the ore in a heap with acidophilic microorganisms to produce a pregnant leach solution which is recovered from the bottom of the heap. An integrated process which comprises subjecting the pregnant leach solution to neutralization and solvent extraction to produce a concentrated zinc solution is also provided. Zinc may be recovered from the concentrated solution by means of electrowinning, either in the absence or presence of manganese. Alternatively zinc may be recovered in the form of a zinc compound.
... |
| Intrapartum monitor patch | 20070191728 | 20070816 |
| The invention provides an integrated patch for the non-invasive monitoring of a laboring woman. The patch incorporates biopotential electrodes for sensing fetal ECG and EMG indicative of myometrial activity. The patch also incorporates a processor for extracting labor activity and fetal heart activity after filtering out maternal ECG from the composite biopotential signal present on the abdomen of the pregnant woman. The fetal monitor patch is thin, flexible, and incorporates a battery and biopotential amplifier network. In the preferred embodiment, the patch is disposable and worn continuously during labor or later stages of pregnancy. In a hospital embodiment for intrapartum monitoring, the patch wirelessly transmits fetal heart activity and myometrial activity to a bedside monitor or a remote monitoring station.
... |
| Pufa supplements | 20070184090 | 20070809 |
| Edible formulations, such as polyunsaturated fatty acids (PUFAs) such as pharmaceutical compositions or nutritional supplements, are disclosed comprising arachidonic acid (ARA). They are adapted to deliver from 150 mg to 1 g per day of ARA and may contain other PUFAs, for example docosahexaenoic acid (DHA). The DHA dosage is from 400 to 600 mg per day, and the ratio of ARA:DHA may be from 1:5 to 5:1. Pharmaceutical compositions comprising ARA and DHA at a ratio of ARA:DHA of 1:1 to 1:2 are also disclosed, as are foodstuffs comprising 0.1 to 5% ARA. Such formulations can be used to increase ARA levels in vivo, for example in pregnant women or for people who have diseases or conditions associated with low ARA levels.
... |
| Screen for pre-eclampsia | 20070185200 | 20070809 |
| It has been demonstrated that the level of asymmetric dimethylarginine (ADMA) increases in women that subsequently develop pre-eclampsia or whose fetus subsequently develops intrauterine growth restriction (IUGR) and that ADMA plays a key role in the development of maternal hypertension. Accordingly, the level of ADMA in a pregnant woman can be used to determine whether or not a pregnant woman is at risk of developing pre-eclampsia or whether or not a fetus is at risk of developing IUGR. Furthermore, antagonists of ADMA activity are useful in the inhibition or prevention of pre-eclampsia or inhibition or prevention of IUGR.
... |
| Methods for preventing cattle reproductive diseases | 20070172877 | 20070726 |
| The present invention relates to methods for treating or preventing diseases or disorders in a pregnant cow and calf nursing a pregnant cow caused by infection by Bovine Viral Diarrhea Virus (BVDV) Types 1 and 2, Bovine Herpes Virus Type-1 (BHV-1), Bovine Respiratory Syncytial Virus (BRSV), Parainfluenza Virus (PIV3), Campylobacter fetus, Leptospira canicola, Leptospira grippotyphosa, Leptospira hardj-prajitno, Leptospira icterohaemmorrhagiae, Leptospira hardjo-bovis and Leptospira pomona by administering to the animal an effective amount of a safe modified live viral combination vaccine further combined with a multivalent bacterin vaccine.
... |
| Method for monitoring a childbirth process | 20070166830 | 20070719 |
| The method is for monitoring a childbirth process of a pregnant woman. A plurality of cervix dilatation data and fetal positioning data are obtained and fed to a device. A plurality of lactate concentrations is measured at time intervals. The measured lactate concentrations are shown on a display of the device at the time intervals to show a trend of the lactate concentrations. The cervix dilation data and the fetal positioning data are also shown on the display. The lactate concentrations are evaluated to determine whether the lactate concentrations are rising to indicate that an individual lactate threshold value of the pregnant woman has been exceeded. The medical practitioner may also evaluate the cervix dilation data and the fetal positioning data.
... |
| Estrogen extraction from pregnant animal urine | 20070161779 | 20070712 |
| A method of extracting oestrogens, conjugated estrogens, equine gonadotropin and equine follicle stimulant from pregnant mares urine which includes the steps of contacting the urine with dispersed particles of adsorber materials of a particle size above 200 microns and subsequently removing the species by washing the adsorber materials in a buffered aqueous solution of pH between 7.5 and 9.5. The compounds are extracted in situ on the mare using an apparatus which consists of a urine holding vessel suspended beneath the belly of the mare and a urine collection device attached to the perineurn of the mare and communicating with the holding vessel in which the urine collection device and/or the holding vessel incorporates a removable urine permeable container of an adsorbent material for said chemical... |
| Methods for preventing cattle reproductive diseases | 20070154943 | 20070705 |
| The present invention relates to methods for treating or preventing diseases or disorders in a pregnant cow and calf nursing a pregnant cow caused by infection by Bovine Viral Diarrhea Virus (BVDV) Types 1 and 2, Bovine Herpes Virus Type-1 (BHV-1), Bovine Respiratory Syncytial Virus (BRSV), Parainfluenza Virus (PIV3), Campylobacter fetus, Leptospira canicola, Leptospira grippotyphosa, Leptospira hardj-prajitno, Leptospira icterohaemmorrhagiae, Leptospira hardjo-bovis and Leptospira pomona by administering to the animal an effective amount of a safe modified live viral combination vaccine further combined with a multivalent bacterin vaccine.
... |
| Methods and apparatus for screening for chromosomal abmormalities | 20070148631 | 20070628 |
| This invention generally relates to methods, apparatus, and computer program code for antenatal screening for chromosomal abnormalities, in particular Down's Syndrome. A method of determining a likelihood of a fetus carried by a pregnant mother having a chromosomal abnormality, a first biological, parameter being suitable for screening said fetus for said chromosomal abnormality, the method comprising: receiving first data from a first stage of pregnancy of said mother, said first data comprising data representing a first value of said first biological parameter, receiving second data from a second, later stage of said pregnancy, said second data comprising data representing a second value of said first biological parameter, and determining likelihood data from said first and second data, said likelihood data representing the likelihood of said fetus... |
| Pregnancy-associated plasma protein-a2 (papp-a2) | 20070141669 | 20070621 |
| The present invention provides nucleotide and amino acid sequences that identify and encode a new protein with homology to pregnancy-associated plasma protein-A (PAPP-A). We denote this protein PAPP-A2. The cDNA encoding PAPP-A2 was derived from human placenta. The present invention also provides for antisense molecules to the nucleotide sequences which encode PAPP-A2, expression vectors for the production of purified PAPP-A2, antibodies capable of binding specifically to PAPP-A2, hybridization probes or oligonucleotides for the detection of PAPP-A2-encoding nucleotide sequences, genetically engineered host cells for the expression of PAPP-A2, use of the protein to produce antibodies capable of binding specifically to the protein, methods for screening for pathologies in pregnant and non-pregnant patients that are based on detection of PAPP-A2 antigen in human body fluids or PAPP-A2-encoding nucleic... |
| Maternity garment with information concerning the unborn child | 20070118962 | 20070531 |
| A garment for a pregnant woman sized to fit a pregnant woman and displaying indicia on the front of the garment that states the expected month of the unborn child's birth, gender of the unborn child, if known, and even, perhaps, the name of the unborn child.
... |
| Method of differentiation from embryo-stem cell of primate to hematogenous cell | 20070124826 | 20070531 |
| A method of differentiation from an embryonic stem cell of a primate into a hematopoietic cell, comprising maintaining an embryonic stem cell of a primate under conditions suitable for induction of differentiation into a hematopoietic cell, transplanting the resulting cell into a fetus in a uterus of a pregnant sheep, rearing the fetus, administering a cytokine specific for a primate to a born lamb, and obtaining a hematopoietic cell of a primate from a sheep obtained by rearing the lamb, a method for producing a hematopoietic cell of a primate, a hematopoietic cell obtained by the method, and a method for producing a chimeric sheep which produces a hematopoietic cell of a primate, comprising maintaining an embryonic stem cell of a primate under conditions suitable for... |
| Composition and method for improved aluminum hydroxide production | 20060292050 | 20061228 |
| An improved method and composition for producing aluminum hydroxide crystals in a Bayer process pregnant liquor, involve the addition of a crystallization modifier comprising a C8-C10 fatty acid, precursors, salts or blends thereof. The alkyl chain of the fatty acid crystallization modifier is free of functional groups. The modifier yields a commercially in the presence and absence of an hydrocarbon oil which dissolves the fatty acid.
... |
| Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen | 20060286109 | 20061221 |
| Combination compositions including C. parvum antigen(s) or epitope(s) of interest with at least one other antigen or epitope of interest from a pathogen that causes enteric infection and/or symptoms and/or recombinant(s) and/or vector(s) and/or plasmid(s) expressing such antigen(s) or epitope(s) of interest and administration of such compositions such as to pregnant mammals and/or newborn or young mammals, for instance, pregnant cows and/or calves such as within the first month of birth, are disclosed and claimed.
... |
| Detection of 5t4 rna in plasma and serum | 20060286578 | 20061221 |
| This invention provides methods for detecting the presence of malignant or premalignant cells, or trophoblastic cells in a human wherein the malignant, premalignant or trophoblastic cells express 5T4. The methods of the invention detect 5T4 RNA in blood, blood plasma, serum, and other bodily fluids. The inventive methods are useful for detection, diagnosis, monitoring, treatment, or evaluation of neoplastic disease, and for the detection and evaluation of placental tissue in pregnant women.
... |
| Reduction of embryonic neural tube defects by pre-or early-administration of germination-activated sporoderm-broken ganoderma lucidum spores to pregnant female | 20060269568 | 20061130 |
| The present invention provides a method for preventing and reducing embryonic neural tube defects (NTDs) caused by cell cycle arrest in the neuroepithelial cells of the embryo. The method comprises administering germination activated sporoderm-broken Ganoderma lucidum spores (“GLSs”) to a female mammal capable of becoming pregnant an effect amount of GLSs. GLSs are preferred to be administered to the female mammal prior to or at an early stage of the pregnancy. The GLSs reduce embryonic NTDs caused by cell cycle arrest in the neuroepithelial cells.
... |
| Markers for prenatal diagnosis and monitoring | 20060252068 | 20061109 |
| Methods and kits are provided for diagnosing, monitoring, or predicting preeclaimpsia in a pregnant woman, trisomy 18 and trisomy 21 in a fetus, as well as for detecting pregnancy in a woman, by quantitatively measuring in the maternal blood the amount of one or more RNA species derived from a set of genetic loci and comparing the amount of the RNA species with a standard control.
... |
| Method and apparatus for analyzing amniotic fluid | 20060247536 | 20061102 |
| Methods and spectra for monitoring fetal growth and predicting birth weight of an infant prior to birth are provided wherein one or more selected biological markers are measured in a sample of amniotic fluid obtained from a pregnant woman. Levels of the selected biochemical markers and/or spectra correlate with one or more medical conditions, such as fetal growth and birth weight of the infant, and gestational diabetes. A measurement probe for in situ measurement can be used safely and repeatedly. Monitoring and/or treatment of maternal and fetal health is also provided.
... |
| Sugar additive blend useful as a binder or impregnant for carbon products | 20060239889 | 20061026 |
| A sugar/additive blend useful as a binder or impregnant for carbon products. Simple sugars as well as sucrose are combined either in solution or in solid form with reactive additives such as ammonium hydrogen phosphate, ammonium chloride and para-toluene sulfuric acid. The sugar/additive blends form more and denser carbon residue than sugar alone when subjected to pyrolysis.
... |
| Treatment of dependence withdrawal | 20060240085 | 20061026 |
| Dosage regimens of buprenorphine to treat withdrawal or abstinence syndrome in a drug dependent or opioid tolerant patient who is pregnant are described. The method includes treating withdrawal or abstinence syndrome of the patient by transdermal administration of an amount of buprenorphine effective to reduce withdrawal symptoms. For example, a first buprenorphine-containing transdermal dosage form for a second dosing period that is no more than about 5 days, the second dosage form comprising the same or a greater dosage of buprenorphine than the first dosage form; and a third buprenorphine-containing transdermal dosage form for a third dosing period that is at least 2 days, the third dosage form comprising the same or a greater dosage of buprenorphine than the second dosage form.
... |
| Method and device for concentrating and stabilizing conjugated estrogens from mare urine | 20060234994 | 20061019 |
| A method and apparatus for concentrating and stabilizing conjugated estrogens from pregnant mare urine on solid adsorbent supports to obtain a starting material for pharmaceuticals that contain a natural mixture of conjugated estrogen mixtures on cartridges in the vicinity of the horses. The adsorbent cartridges can be loaded at the site of urine collection so it is unnecessary to transport large volumes of urine to a central processing point. The loading process can take continuously over a period of weeks until the column is saturated. The effluent urine remains at the site where facilities for its disposal are available. Only the loaded cartridge is transported, and transport can occur at longer intervals of up to several weeks. The stability of the conjugated estrogens on the adsorber... |
| Audio speakers devise for delivering the sound of music, learning material or audio - recorded voice of parent(s) to unborn child through a pregnant woman's stomach | 20060228685 | 20061012 |
| The technology/invention or audio-speakers devise for delivering the sound of music, learning material or audio-recorded voice to unborn child through a pregnant woman's stomach
... |
| Nutritional preparations | 20060217385 | 20060928 |
| Compositions and methods for improving the nutritional and physiological status of a woman and her child during all stages of pregnancy are provided herein. This includes pre-conceptional women, pregnant women, and post-natal women (both lactating and non-lactating mothers). The compositions are particularly useful for the neurological, visual, and cognitive development of an embryo, fetus, or infant and the nutritional and physiological well-being of the mother, fetus, and infant. The compositions contain one or more folates, such as a reduced folate and/or folic acid, and one or more essential fatty acids (EFA), such as an omega-3 and/or omega-6 fatty acid. The addition of the essential fatty acid improves upon the folate containing nutritional preparations described in the prior art. The one or more folates and essential fatty... |
| Nutritional preparations | 20060217386 | 20060928 |
| Compositions and methods for improving the nutritional and physiological status of a woman and her child during all stages of pregnancy are provided herein. This includes pre-conceptional women, pregnant women, and post-natal women (both lactating and non-lactating mothers). The compositions are particularly useful for the neurological, visual, and cognitive development of an embryo, fetus, or infant and the nutritional and physiological well-being of the mother, fetus, and infant. The compositions contain one or more folates, such as a reduced folate and/or folic acid, and one or more essential fatty acids (EFA), such as an omega-3 and/or omega-6 fatty acid. The addition of the essential fatty acid improves upon the folate containing nutritional preparations described in the prior art. The one or more folates and essential fatty... |
| Biological data measurement system for pregnant women | 20060217630 | 20060928 |
| Disclosed is a maternity biodata measurement system, wherein a sum of a pre-pregnancy energy expenditure and a pregnancy extra energy amount of a subject is determined as an energy amount necessary for the subject in a pregnancy period. In particular, the pregnancy extra energy amount is determined based on pre-pregnancy body-mass index data and elapsed pregnancy-period data about the subject, so as to allow the necessary energy amount to be determined as a value appropriate for the subject. The maternity biodata measurement system of the present invention makes it possible to measure a necessary energy amount for a pregnant woman on an individual basis.
... |
| Nissen pillow | 20060179573 | 20060817 |
| An apparatus and method for properly positioning a patient to allow rapid and effective endotracheal intubation during an anesthetic induction is disclosed. The apparatus includes a plurality of inflatable sections for supporting the patient's head and upper back, where the inflatable sections are independently inflatable and deflatable with respect to one another so that the patient's ear and sternum can be aligned in the same horizontal plane. The apparatus also includes an anchoring means that is attached to at least one of the plurality of inflatable sections for anchoring the apparatus in place. An air system connected to the plurality of inflatable sections and including separate connections to the individual inflatable sections operates to provide air to the apparatus. The apparatus optionally includes an independently inflatable... |
| Method for monitoring a childbrith process | 20060180161 | 20060817 |
| The method is for monitoring a childbirth process of a pregnant woman. In a measuring step, a lactate concentration of vaginal fluids is measured. In a comparison step, it is determined if the measured lactate concentration is greater than a predetermined lactate concentration that indicates that amniotic fluid has passed from an amnion of the pregnant woman. In a measuring step, the lactate concentration is measured. In a comparison step, it is determined if the measured lactate concentration is greater than a lactate threshold interval. When the lactate concentration is less than the lactate threshold interval the pregnant woman is stimulated in a stimulating step to give birth.
... |
| Diagnosis of preeclampsia | 20060183175 | 20060817 |
| The present invention provides methods and compositions related to the detection and/or monitoring of the levels of angiogenic factors, specifically VEGF, PlGF and sFlt-1, in urine samples obtained from pregnant women and the effects of such levels on the risk of developing complications of pregnancy, including hypertensive disorders such as preeclampsia, in the first, second, and/or third trimester of pregnancy. The present invention also provides kits for identifying and screening patients at risk of developing a complication of pregnancy, such as preeclampsia.
... |
| Non-invasive measurement of suprasystolic signals | 20060178585 | 20060810 |
| An apparatus for assessing cardiovascular status of a mammal comprises a system for locally applying a pressure to an artery capable of restricting blood flow through said artery, a wideband external pulse transducer having an output and situated to measure suprasystolic signals proximate to said artery, and a computing device receiving said output for calculating vascular compliance values. The method described is particularly useful for determining cardiac output, assessing whether a pregnant female has preeclampsia or a patient has cardiac insufficiency, or assessing cardiac arrhythmia.
... |
| Method of improving antioxidant status of an infant | 20060171993 | 20060803 |
| The present invention relates generally to a method of improving the antioxidant status of an infant. More particularly, the present invention relates to a method of improving the antioxidant status of an infant by administering a mixture of natural tocopherols. The natural tocopherol mixture is an effective blend of α- and γ-tocopherol. For ease of administration and improved taste, the mixture of natural tocopherols are typically delivered in vehicle which may be in the form, for example, of a tablet, capsule, liquid, and nutritional formula. The present invention also relates to a method of improving the antioxidant status of an infant by supplementing the lactating woman wherein the supplemented breast milk is fed to the infant. Additionally, the present invention relates to a method of improving... |
| Method for determination of likelihood of occurrence of preterm labor in pregnant females | 20060166295 | 20060727 |
| The presence of 3-chlorotyrosine in vaginal secretions in a predictor of the likelihood preterm premature rupture of the fetal membranes, i.e., the chorioamnion and/or the occurrence of the risk of preterm labor. 3-chlorotyrosine is a marker for the excessive production of hypochlorous acid which causes focal areas of increased collagen destruction in the chorioamnion, preterm premature rupture of membranes, or increased production of postaglandin and preterm labor. The inventive method comprises determining the likelihood of the occurrence of preterm premature rupture of membranes or increased production of postaglandin and preterm labor in a pregnant female by obtaining a sample of the females vaginal secretions, and analyzing the secretions for the presence and amount of 3-chlorotyrosine in the sample. Various antibody-based tests can be used to measure... |
| Basal metabolic rate measuring device | 20060167373 | 20060727 |
| A basal metabolic rate measuring device capable of measuring the basal metabolic rate of a pregnant woman easily and accurately is provided by improving a known basal metabolic rate measuring device capable of calculating a basal metabolic rate based on the fat free mass data and age data of a subject. The basal metabolic rate measuring device calculates the fat free mass data of the body of a pregnant subject and calculates the basal metabolic rate of the subject based on at least the fat free mass data and age data. The fat free mass data of the body of the subject is calculated based on at least the body height data, body weight data, impedance data and fetal part weight data of the subject by... |
| Pharmaceutical dosage form bearing pregnancy-friendly indicia | 20060159750 | 20060720 |
| A pharmaceutical dosage form comprising at least one active ingredient and destined for administration to pregnant women. The pharmaceutical dosage form bears pregnancy-friendly indicia apt to improve patient compliance with medically recommended dosage regimen resulting in improved product effectiveness. The pregnancy-friendly indicia is also apt to diminish the incidence of erroneous dispensing of or erroneous ingestion of pharmaceutical dosage forms not intended for pregnant women. Also disclosed is a method for achieving improved patient compliance resulting in improved product effectiveness. Also disclosed is a method for diminishing the incidence of erroneous dispensing of or erroneous ingestion of dosage forms not intended for pregnant women. Said methods comprising providing a pharmaceutical dosage form, intended for use by pregnant women, bearing pregnancy-friendly indicia apt to graphically distinguish dosage... |
| No maintenance lethal mosquito breeding trap | 20060150473 | 20060713 |
| A device into which gravid (pregnant) female mosquitos are attracted to deposit their eggs and where both the adult and her offspring are then eliminated. The trap is set in the out-of-doors at the onset of the mosquito breeding season and is replenished by rain water and, by its unique construction, a larvicide within is protected from flushing and photo degradation thereby making it maintenance free throughout the mosquito breeding season. The low cost trap is constructed from biodegradable paperboard and at the end of the mosquito breeding season, decomposes, thereby foreclosing the possibility that the trap will become a breeding incubator.
... |
| Treatment of pre-eclampsia in pregnant women using targeted apheresis | 20060153835 | 20060713 |
| This invention uses “targeted apheresis” to treat pregnant women who are at risk of developing eclampsia. “Targeted Apheresis” is a process whereby the sFlt-1 receptors responsible for causing the disease symptoms are selectively removed from the blood by passing the blood through a cartridge containing either immobilized PIGF, and/or through a cartridge containing immobilized anti-sFlt-1 antibody. The sFlt-1 receptor is bound out and the cleaned blood is returned to the patient Removal of circulating sFlt-1 receptors will diminish the risk of developing eclampsia during pregnancy.
... |
| Ringworm vaccine | 20060147475 | 20060706 |
| A ringworm vaccine is disclosed comprising antigen isolated from at least one dermatophyte and a suitable carrier. The “antigen” can include a single antigen from a dermatophyte or a plurality of antigens as long as at least one antigen is included which will produce a sufficient immune response to confer resistance to ringworm infection upon the recipient of the vaccine. The antigen can also be isolated from more than one dermatophyte. If a preparation from more than one dermatophyte is made the antigen can include antigens which are common to all species of dermatophytes employed and/or antigens which are only specific to certain species. A method of producing such a ringworm vaccine is also disclosed. The method comprises making an antigen preparation comprising the dermatophyte antigen... |
| Insulin-like growth factor binding protein-4 protease | 20060148018 | 20060706 |
| Methods for screening for altered focal proliferation states in non-pregnant patients, which include detecting levels of pregnancy-associated plasma protein-A (PAPP-A), are described. Methods for identifying agents that alter the protease activity of PAPP-A, and pharmaceutical compositions and medical devices that include such agents also are described.
... |
| Equine relaxin as a measure of treatment efficacy | 20060141638 | 20060629 |
| A method for predicting treatment efficacy in pregnant mares affected by a disease or condition that alters placental function and results in a problematic pregnancy or delivery in the mare that is related to measurement of plasma relaxin levels is provided.
... |
| Processes for recovering metals from ores using organic solvent extraction and aqueous stripping at selected temperature differentials | 20060117908 | 20060608 |
| The disclosed invention concerns a process comprising: (a) providing a pregnant leach solution comprising copper values; (b) contacting the pregnant leach solution with an organic phase comprising a copper extractant at an extraction temperature, Text, to form a loaded organic phase comprising the metal values; (c) contacting the loaded organic phase with an aqueous stripping solution at a stripping temperature, Tstrip, to form a copper-enriched stripping solution; wherein the difference in temperature (ΔT) between the stripping temperature and the extraction temperature according to equation (I): ΔT=Tstrip−Text is less than or equal to about 10° C. In other increasingly more preferred embodiments of the invention, the difference in temperature (ΔT) is less than or equal to about 5° C., less than or equal to about 2.5° C.,... |
| Baby gender message candle | 20060110697 | 20060525 |
| A device for containing, transforming or otherwise communicating a message intended to predict a future event, particularly the gender of a pregnant mother's baby, is disclosed. A method of building a composite candle is also disclosed. The invention also pertains to a method whereby the device or the contents or message of the device are selected by a third party based upon submitted information in regard to the mother and pregnancy. The information utilized in the selection of the message device may be furnished by any means, including the Internet or Internet website. The invention includes a method of selecting a candle containing a message predictive of the gender of a pregnant mother's child, based upon selected information. The message can be communicated by lighting the... |
| Method of detecting early pregnancy at high accuracy by measuring hcg and hyperglycosylated hcg concentrations equally | 20060105411 | 20060518 |
| The present invention relates to methods for analyzing concentrations of hyperglycosylated hCG (H-hCG) and hCG equally in blood, serum or urine samples, preferably urine samples, from female patients to determine with an unexpectedly high measure of accuracy whether or not the patient is pregnant and to appropriately monitor hCG levels during the course of pregnancy. In preferred aspects of the present invention, the method utilizes an assay system which can be used in the home or at a point of care facility in a convenient manner with serum or urine samples, in a highly accurate predictive manner. It can also be used in a serum professional laboratory quantitative test.
... |
| Animal food additive and animal food containing said additive | 20060099322 | 20060511 |
| The invention relates to an animal food additive for working animals which are bred and exist in a state of gravidity, consisting of a proportion of raw fibers. In order to obtain quick satiation in pregnant working animals using feeding systems such as satiate feeding, the animal food additive contains, according to the invention, a raw fiber concentrate of fibrillated lignocellulose.
... |
